{"meta":{"page":1,"per_page":50,"max_per_page":100,"total":45,"total_is_capped":false,"direct_labels_cover":0,"predictions_cover":45,"direct_label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline (scores rank; they never assert a category)","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12","author_layer_release":"2026-06-26"},"query_hash":"7626a6004b58","filters":{"venue":"Expert Opinion on Therapeutic Patents"}},"results":[{"id":"W1982970232","doi":"10.1517/13543776.2013.780598","title":"Diuretics with carbonic anhydrase inhibitory action: a patent and literature review (2005 – 2013)","year":2013,"lang":"en","type":"review","venue":"Expert Opinion on Therapeutic Patents","topic":"Enzyme function and inhibition","field":"Biochemistry, Genetics and Molecular Biology","cited_by":295,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"McMaster University","keywords":"Carbonic anhydrase; Pharmacology; Chlorthalidone; Chemistry; Furosemide; Diuretic; Hydrochlorothiazide; Bumetanide; Drug; Acetazolamide; Medicine; Internal medicine; Blood pressure; Enzyme; Biochemistry","authors":[{"name":"Fabrizio Carta","is_ca":false},{"name":"Claudiu T. Supuran","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.0921937601477758,"gpt":0.3382070873180926,"spread":0.2460133271703168,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001524865,0.0006398594,0.0007895319,0.0001114008,0.0001188062,0.00007451331,0.0001652868,0.0005549365,0.00009918643],"category_scores_gemma":[0.00001218936,0.0004320159,0.0002607442,0.000164752,0.00009191885,0.00001476174,0.00007069598,0.0004094336,0.00006573794],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00006975407,"about_ca_system_score_gemma":0.0001232605,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000005905185,"about_ca_topic_score_gemma":0.000001928009,"domain_scores_codex":[0.9978071,0.0002892777,0.0004764389,0.0007599393,0.0003040454,0.0003631733],"domain_scores_gemma":[0.9986764,0.00001528155,0.0003469309,0.0006344627,0.0001202073,0.0002067518],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00007576971,0.000261998,0.000003486984,0.008278318,0.000398864,0.00001248012,0.00004738185,4.980312e-7,0.0004162678,0.00003127282,0.08117785,0.9092958],"study_design_scores_gemma":[0.0004912729,0.0006085711,0.000001984896,0.0388214,0.00006511089,0.0001772216,0.00001216756,0.00000289427,0.0001867833,0.000003117493,0.9591234,0.0005060948],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.000011168,0.9972133,0.00004572007,0.0002625528,0.00105359,0.001174647,0.00004052294,0.00003707014,0.0001614509],"genre_scores_gemma":[0.00003202503,0.9934326,0.00004245242,0.002340314,0.0008455915,0.0004997131,0.001658286,0.00009531918,0.001053636],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9087897,"threshold_uncertainty_score":0.9998131,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2069045375","doi":"10.1517/13543776.2011.539205","title":"Signal transducer and activator of transcription 3 inhibitors: a patent review","year":2010,"lang":"en","type":"review","venue":"Expert Opinion on Therapeutic Patents","topic":"Cytokine Signaling Pathways and Interactions","field":"Medicine","cited_by":101,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto","funders":"","keywords":"STAT protein; STAT3; Regulator; In vivo; Computational biology; Small molecule; Peptidomimetic; Medicine; Cancer research; stat; Biology; Pharmacology; Signal transduction; Cell biology; Peptide; Biochemistry; Gene; Genetics","authors":[{"name":"Brent D. G. Page","is_ca":true},{"name":"Daniel P. Ball","is_ca":true},{"name":"Patrick T. Gunning","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1864480791170665,"gpt":0.3904915374547805,"spread":0.204043458337714,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002356925,0.0005429828,0.001911854,0.0002481712,0.00007258456,0.00001668733,0.0001294026,0.0004017481,0.0005913718],"category_scores_gemma":[0.00001809113,0.0003759571,0.000846114,0.0002497583,0.00008551126,0.00008553411,0.00001485649,0.0008085134,0.00003270901],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00008344615,"about_ca_system_score_gemma":0.0001794816,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002376449,"about_ca_topic_score_gemma":3.18019e-7,"domain_scores_codex":[0.9975538,0.0001859437,0.001003539,0.0005330544,0.0004551974,0.0002684536],"domain_scores_gemma":[0.998721,0.00008942148,0.000441088,0.0004355229,0.0001190691,0.0001938916],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00008406032,0.0004761054,0.000001780127,0.01312243,0.0002914708,0.00000342009,0.0001651086,1.870914e-8,0.007963678,0.00002778634,0.0004766713,0.9773875],"study_design_scores_gemma":[0.0006586642,0.0006695918,0.00000701319,0.1219633,0.0002672861,0.000107578,0.00001360071,0.000004307053,0.001864363,0.000006934092,0.8741549,0.0002824446],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00002784829,0.9963627,0.00006904539,0.0003446242,0.001275891,0.00163521,0.00008222274,0.00005300908,0.0001493748],"genre_scores_gemma":[0.0006000315,0.9973649,0.00005340587,0.0008082137,0.0004830382,0.0002665352,0.0002768239,0.00009218304,0.0000548779],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.977105,"threshold_uncertainty_score":0.9998692,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2068430448","doi":"10.1517/13543770802672598","title":"Recent advances in the development of NS5B polymerase inhibitors for the treatment of hepatitis C virus infection","year":2009,"lang":"en","type":"review","venue":"Expert Opinion on Therapeutic Patents","topic":"Hepatitis C virus research","field":"Medicine","cited_by":100,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Boehringer Ingelheim (Canada)","funders":"","keywords":"Hepatitis C virus; Medicine; Cirrhosis; Disease; Virus; Liver disease; Hepatitis C; Immunology; Intensive care medicine; Virology; Internal medicine","authors":[{"name":"Pierre L. Beaulieu","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1976010030924328,"gpt":0.4564261719388696,"spread":0.2588251688464369,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004681982,0.0004069149,0.001209683,0.000333142,0.0001212374,0.00001323422,0.0002320061,0.0002125694,0.00004539544],"category_scores_gemma":[0.00005646655,0.0002079758,0.0004093112,0.000490361,0.00009115232,0.00005697073,0.00001681556,0.0001992775,0.00001277492],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005486573,"about_ca_system_score_gemma":0.000478651,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003432531,"about_ca_topic_score_gemma":0.0002142326,"domain_scores_codex":[0.9970066,0.0004192406,0.001129527,0.0003712643,0.0007252633,0.0003481319],"domain_scores_gemma":[0.9982238,0.0005657744,0.0004620689,0.0005587828,0.0001205911,0.00006892315],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001583453,0.001384195,0.0002980196,0.0006914312,0.0002421788,0.000001800317,0.001577554,8.967446e-7,0.00001165854,0.00001178759,0.00004685454,0.9955752],"study_design_scores_gemma":[0.001170392,0.001969087,0.0006129934,0.004972572,0.00005732651,0.000004058565,0.00003788047,0.00001378828,0.0008838941,0.00001033313,0.9900967,0.0001709659],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001700353,0.9947041,0.0001031374,0.0001680731,0.0006565528,0.004007013,0.00004722563,0.00001503436,0.0001288409],"genre_scores_gemma":[0.0004087009,0.9972694,0.00008950369,0.0001562147,0.0002085417,0.001599502,0.0001972483,0.00004533578,0.00002554305],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9954043,"threshold_uncertainty_score":0.8481007,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2067881291","doi":"10.1517/13543776.2013.736494","title":"Tanshinone derivatives: a patent review (January 2006 – September 2012)","year":2012,"lang":"en","type":"review","venue":"Expert Opinion on Therapeutic Patents","topic":"Traditional Chinese Medicine Analysis","field":"Medicine","cited_by":92,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"McGill University; Jewish General Hospital","funders":"Canadian Institutes of Health Research","keywords":"Neuroprotection; Prodrug; Pharmacology; In vivo; Chemistry; Kinase; Medicine; Biochemistry; Biology","authors":[{"name":"Xiaohong Tian","is_ca":true},{"name":"Jian Wu","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.3000212256577778,"gpt":0.417760204920846,"spread":0.1177389792630682,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["metaepi_narrow","insufficient_payload"],"category_scores_codex":[0.0006155348,0.001284941,0.004252961,0.0005479096,0.000146058,0.00002347643,0.0004438078,0.0004909969,0.0031159],"category_scores_gemma":[0.00005551664,0.000827478,0.001747976,0.0009689502,0.0001477376,0.0002240373,0.00008312183,0.001051708,0.00298999],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004577674,"about_ca_system_score_gemma":0.0003170893,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002160612,"about_ca_topic_score_gemma":7.986745e-7,"domain_scores_codex":[0.9944166,0.0006909182,0.001634215,0.0009870209,0.001467608,0.0008036189],"domain_scores_gemma":[0.99671,0.0002890831,0.0008192323,0.001351822,0.0002123629,0.0006175212],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00005079245,0.001066444,0.00005932229,0.02231709,0.00245125,0.0000501211,0.0001003006,1.129291e-7,0.000002658015,0.00005636359,0.08159833,0.8922472],"study_design_scores_gemma":[0.000828317,0.0002998656,0.0002586616,0.1071158,0.001446284,0.000274708,0.00001253051,0.000002925708,0.000001655654,0.00002530231,0.8890791,0.0006548635],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[8.779245e-7,0.9901389,0.0001381533,0.001047336,0.001464054,0.002588439,0.0001461945,0.0001757802,0.004300246],"genre_scores_gemma":[0.00001650562,0.9801339,0.0001406026,0.01011151,0.002017137,0.000927229,0.003687729,0.0002154603,0.002749915],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.8915923,"threshold_uncertainty_score":0.9999902,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2112661022","doi":"10.1517/13543776.2014.1000303","title":"Therapeutic uses of furin and its inhibitors: a patent review","year":2015,"lang":"en","type":"review","venue":"Expert Opinion on Therapeutic Patents","topic":"Cellular transport and secretion","field":"Biochemistry, Genetics and Molecular Biology","cited_by":88,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Université de Sherbrooke","funders":"","keywords":"Furin; Context (archaeology); Clinical trial; Medicine; Drug discovery; Computational biology; Pharmacology; Bioinformatics; Biology; Biochemistry; Enzyme","authors":[{"name":"Frédéric Couture","is_ca":true},{"name":"Anna Kwiatkowska","is_ca":true},{"name":"Yves L. Dory","is_ca":true},{"name":"Robert Day","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1731927925268858,"gpt":0.363310240735042,"spread":0.1901174482081562,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003637722,0.0005444163,0.001199941,0.0001008053,0.00004820966,0.0000143403,0.0002803507,0.0004278434,0.00003668567],"category_scores_gemma":[0.00001247845,0.0004089216,0.0004444199,0.0001570581,0.00005246248,0.000005888189,0.00006653344,0.0001911311,0.0000256162],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003381392,"about_ca_system_score_gemma":0.000154129,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000007274263,"about_ca_topic_score_gemma":6.419124e-7,"domain_scores_codex":[0.9976779,0.0003027988,0.0007463857,0.0006162867,0.0003686719,0.0002879483],"domain_scores_gemma":[0.9987648,0.00001602487,0.0004219683,0.0005189592,0.000132384,0.0001458983],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00007305743,0.0002660287,0.0000180662,0.01028297,0.0004908785,0.000003574518,0.00008133581,1.897579e-7,0.002803234,0.00007067435,0.0002945898,0.9856154],"study_design_scores_gemma":[0.000406184,0.0004907306,0.000007140378,0.01706612,0.0001063231,0.00002129607,0.00001076063,0.00000272226,0.000627155,0.00001549477,0.9808302,0.0004159053],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00004201531,0.9979265,0.0000793257,0.00004885538,0.0006445332,0.001106409,0.00005495334,0.00001808125,0.00007932699],"genre_scores_gemma":[0.0006137735,0.9951499,0.000009684973,0.0004373827,0.0002911233,0.000161278,0.003138701,0.00008395489,0.0001141627],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9851995,"threshold_uncertainty_score":0.9998363,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1969081293","doi":"10.1517/13543776.2014.898753","title":"LEDGINs, non-catalytic site inhibitors of HIV-1 integrase: a patent review (2006 – 2014)","year":2014,"lang":"en","type":"review","venue":"Expert Opinion on Therapeutic Patents","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":83,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Integrase; Allosteric regulation; Integrase inhibitor; Human immunodeficiency virus (HIV); Biology; Computational biology; Pharmacology; Virology; Enzyme; Antiretroviral therapy; Biochemistry; Viral load","authors":[{"name":"Jonas Demeulemeester","is_ca":false},{"name":"Patrick Chaltin","is_ca":false},{"name":"Arnaud Marchand","is_ca":false},{"name":"Marc De Maeyer","is_ca":false},{"name":"Zeger Debyser","is_ca":false},{"name":"Frauke Christ","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.07985944761990504,"gpt":0.3579603441142575,"spread":0.2781008964943525,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005529197,0.001198679,0.004222106,0.0005401428,0.00009486423,0.00002294292,0.0003890831,0.0004543511,0.0004943234],"category_scores_gemma":[0.00005355698,0.0007783201,0.001337104,0.0005050211,0.0001215878,0.00006934007,0.0001214743,0.0005633868,0.003423905],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005001365,"about_ca_system_score_gemma":0.0004907451,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002455282,"about_ca_topic_score_gemma":7.56427e-7,"domain_scores_codex":[0.9952361,0.0003151047,0.001866061,0.001004111,0.0009313623,0.0006472917],"domain_scores_gemma":[0.9969569,0.0001640877,0.001023114,0.001301848,0.0001847251,0.0003692691],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0000573104,0.00088627,0.0001170146,0.0271991,0.001461194,0.00003045364,0.0001826464,6.980732e-8,0.000003534401,0.00001955254,0.1072762,0.8627666],"study_design_scores_gemma":[0.001343784,0.0002820684,0.0000199157,0.1755349,0.0006157666,0.00005520739,0.0000125862,0.000007646641,0.00004029404,0.000004595188,0.8215383,0.000544847],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.000002700504,0.9932998,0.00007291196,0.0007982265,0.001467475,0.003252965,0.0001150728,0.00008105658,0.0009097292],"genre_scores_gemma":[0.00004543864,0.9879836,0.0001393137,0.001070955,0.0003921343,0.0006718119,0.005293379,0.0001758048,0.004227489],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.8622218,"threshold_uncertainty_score":0.9994668,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2006746802","doi":"10.1517/13543776.2010.505604","title":"17β-Hydroxysteroid dehydrogenase inhibitors: a patent review","year":2010,"lang":"en","type":"review","venue":"Expert Opinion on Therapeutic Patents","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":82,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Université Laval; Centre hospitalier de l'Université Laval","funders":"Canadian Institutes of Health Research","keywords":"Dehydrogenase; Hydroxysteroid dehydrogenase; Chemistry; Biochemistry; Enzyme; Pharmacology; Biology","authors":[{"name":"Donald Poirier","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.07400655074951908,"gpt":0.3529148804783789,"spread":0.2789083297288599,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0003654246,0.0009938823,0.001488038,0.0001418568,0.0001571769,0.00004613697,0.0006614646,0.001323422,0.0000516562],"category_scores_gemma":[0.00004226672,0.0007132781,0.001184796,0.0002536311,0.0001019187,0.000006194488,0.0001809014,0.000879685,0.0005924186],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00006527094,"about_ca_system_score_gemma":0.0002141916,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000007071246,"about_ca_topic_score_gemma":3.591822e-7,"domain_scores_codex":[0.9963519,0.0005470885,0.000925054,0.001090835,0.0004460216,0.0006391142],"domain_scores_gemma":[0.997728,0.00003413281,0.0005513051,0.001291873,0.00007402048,0.0003206354],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00003420466,0.0003155602,0.000001689816,0.003924116,0.0005133651,0.00001985789,0.00001703438,2.404309e-7,0.002186296,0.00001104445,0.005852098,0.9871245],"study_design_scores_gemma":[0.0004957875,0.0006123509,3.199318e-7,0.02827139,0.0001080725,0.0001579595,0.000002480617,0.000003134292,0.002293726,0.000005083032,0.9672825,0.0007671298],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00003568856,0.9949639,0.000016002,0.00007726449,0.002615097,0.001881474,0.00004825469,0.00006315517,0.0002991908],"genre_scores_gemma":[0.00005407098,0.9943662,0.00003203884,0.001679163,0.001068237,0.0006303394,0.001667978,0.0002043506,0.0002975959],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9863574,"threshold_uncertainty_score":0.9999731,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2500524559","doi":"10.1080/13543776.2016.1216545","title":"Therapeutic significance of quinolines: a patent review (2013-2015)","year":2016,"lang":"en","type":"review","venue":"Expert Opinion on Therapeutic Patents","topic":"Synthesis and Reactivity of Heterocycles","field":"Chemistry","cited_by":68,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Saskatchewan","funders":"","keywords":"Quinoline; Pharmacophore; Antimicrobial; Broad spectrum; Combinatorial chemistry; Chemistry; Pharmacology; Medicine; Computational biology; Biology; Bioinformatics; Organic chemistry","authors":[{"name":"S.M. Ali Hussaini","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1785058521527395,"gpt":0.3792114764262831,"spread":0.2007056242735437,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003643557,0.001145327,0.003348704,0.0001969733,0.0001217795,0.00003333381,0.001134966,0.0006517008,0.001644576],"category_scores_gemma":[0.00004269948,0.0006867974,0.001558661,0.0001755453,0.00021312,0.0001126473,0.0001159233,0.0004542182,0.0005653582],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002416133,"about_ca_system_score_gemma":0.0002052982,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00005279602,"about_ca_topic_score_gemma":6.5123e-7,"domain_scores_codex":[0.9953486,0.000364428,0.001587572,0.001093106,0.0008952247,0.0007110466],"domain_scores_gemma":[0.9958095,0.0006145169,0.001590222,0.001654786,0.0001250191,0.0002059507],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0000335803,0.0004660379,0.000002720958,0.02083509,0.000722016,0.000003480072,0.00004607149,4.417063e-8,0.0005644145,0.00002915238,0.001201573,0.9760958],"study_design_scores_gemma":[0.0003508517,0.00007257327,0.000002380575,0.1677194,0.0001125899,0.0000223239,0.00001640007,0.000001603081,0.0007195665,0.00005590785,0.830233,0.0006933921],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.000002158757,0.9965452,0.00005163405,0.0004313552,0.001033015,0.0008583362,0.0001615702,0.0001339495,0.0007827963],"genre_scores_gemma":[0.000161415,0.9972252,0.00002260738,0.0005643337,0.0005800633,0.0006853907,0.0001138871,0.0002082696,0.0004388266],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9754024,"threshold_uncertainty_score":0.9995583,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1769059961","doi":"10.1517/13543776.2015.1086749","title":"A STAT inhibitor patent review: progress since 2011","year":2015,"lang":"en","type":"review","venue":"Expert Opinion on Therapeutic Patents","topic":"Cytokine Signaling Pathways and Interactions","field":"Medicine","cited_by":55,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Dairy Farmers of Ontario; University of Toronto","funders":"","keywords":"STAT5; stat; SH2 domain; Computational biology; STAT3; Cancer research; Biology; Kinase; Phosphorylation; Genetics","authors":[{"name":"Ping‐Shan Lai","is_ca":true},{"name":"David A. Rosa","is_ca":true},{"name":"Rodolfo F. Gómez‐Biagi","is_ca":true},{"name":"Daniel P. Ball","is_ca":true},{"name":"Andrew E. Shouksmith","is_ca":true},{"name":"Patrick T. Gunning","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.3069633868370701,"gpt":0.4409019624140757,"spread":0.1339385755770056,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0004167905,0.000831725,0.002468434,0.0002836775,0.0001167238,0.00004710027,0.0003163916,0.0003475334,0.0005613154],"category_scores_gemma":[0.00004151553,0.0005575118,0.0009252463,0.000277625,0.0001003258,0.0000996859,0.00009733359,0.0007647356,0.001903585],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005074076,"about_ca_system_score_gemma":0.0005647183,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002347776,"about_ca_topic_score_gemma":2.443296e-7,"domain_scores_codex":[0.9961602,0.0003340605,0.001189471,0.0008449891,0.0009255445,0.0005456994],"domain_scores_gemma":[0.9974647,0.00007492247,0.0006620726,0.001011036,0.0003598611,0.0004274095],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00007978442,0.0007211172,0.000003707605,0.007904183,0.0003798286,0.00003156146,0.00007583486,4.28322e-8,0.000007451281,0.00003246561,0.04858255,0.9421815],"study_design_scores_gemma":[0.0007249439,0.0009592096,0.000002772829,0.1225037,0.0001973046,0.0001793932,0.00001356665,0.000006679323,0.00002597182,0.000008507209,0.8749077,0.0004702061],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[6.707625e-7,0.991973,0.00002088139,0.000789149,0.003643975,0.002844051,0.0001263313,0.0001832851,0.0004186764],"genre_scores_gemma":[0.000008359785,0.9934686,0.00009551283,0.00249028,0.001127518,0.0009201943,0.001081215,0.0001715362,0.0006368107],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9417112,"threshold_uncertainty_score":0.9996876,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2590195415","doi":"10.1080/13543776.2017.1297796","title":"Tropomyosin receptor kinase inhibitors: an updated patent review for 2010-2016 –<i>Part I</i>","year":2017,"lang":"en","type":"review","venue":"Expert Opinion on Therapeutic Patents","topic":"Nerve injury and regeneration","field":"Neuroscience","cited_by":50,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Alberta","funders":"","keywords":"Trk receptor; Tropomyosin receptor kinase A; Kinase; Context (archaeology); Biology; Receptor; Neurotrophin; Cell biology; Biochemistry","authors":[{"name":"Justin J. Bailey","is_ca":true},{"name":"Ralf Schirrmacher","is_ca":true},{"name":"Kristen B. Farrell","is_ca":true},{"name":"Vadim Bernard‐Gauthier","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.4089902481238907,"gpt":0.4358830275645397,"spread":0.026892779440649,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007080833,0.001039298,0.001985473,0.0002263608,0.0008239752,0.0002466055,0.001282393,0.0005765816,0.0003316643],"category_scores_gemma":[0.0001455133,0.0007153092,0.0009769014,0.0002274055,0.0001916847,0.0004891847,0.0001112232,0.0004844276,0.0007274448],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002310746,"about_ca_system_score_gemma":0.000295036,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001549487,"about_ca_topic_score_gemma":6.269771e-7,"domain_scores_codex":[0.9941191,0.00143791,0.001401206,0.001631916,0.0006721551,0.0007376916],"domain_scores_gemma":[0.996066,0.0001444481,0.001440379,0.00187659,0.0001342988,0.000338307],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00007179845,0.0004830359,1.134182e-7,0.00226338,0.00005177487,0.00000391766,0.00002495477,1.567609e-7,0.001856536,0.0001901572,0.08989716,0.905157],"study_design_scores_gemma":[0.0006493441,0.0007174005,1.424982e-7,0.0358181,0.00007227321,0.00001663817,0.000002791959,0.00001109488,0.009035669,0.00003853905,0.9527927,0.0008452722],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.000002285163,0.9796466,0.00006562268,0.0006390535,0.01450787,0.0042781,0.0005413975,0.0001924449,0.0001266822],"genre_scores_gemma":[0.000005058435,0.9865326,0.000072391,0.003688607,0.002393395,0.001741755,0.002295437,0.0002002199,0.00307052],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9043117,"threshold_uncertainty_score":0.9995298,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4231919180","doi":"10.1080/13543776.2017.1297797","title":"Tropomyosin receptor kinase inhibitors: an updated patent review for 2010-2016 – <i>Part II</i>","year":2017,"lang":"en","type":"review","venue":"Expert Opinion on Therapeutic Patents","topic":"Signaling Pathways in Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":47,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Alberta","funders":"","keywords":"Trk receptor; Tropomyosin receptor kinase A; Drug development; Medicine; Pharmacology; Cancer research; Internal medicine; Drug; Receptor; Neurotrophin","authors":[{"name":"Justin J. Bailey","is_ca":true},{"name":"Ralf Schirrmacher","is_ca":true},{"name":"Kristen B. Farrell","is_ca":true},{"name":"Vadim Bernard‐Gauthier","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.2270398082199384,"gpt":0.4052185314502031,"spread":0.1781787232302647,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000603162,0.001050955,0.001639433,0.0001011115,0.0004954764,0.000093331,0.001310422,0.0007749268,0.0001780792],"category_scores_gemma":[0.000125062,0.0008281498,0.001160901,0.000101519,0.0001571366,0.00001761848,0.0002610068,0.0002944565,0.0001578753],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001211577,"about_ca_system_score_gemma":0.0004972609,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001368062,"about_ca_topic_score_gemma":5.408469e-7,"domain_scores_codex":[0.9956691,0.0005798985,0.001106857,0.001495623,0.0004425175,0.0007060456],"domain_scores_gemma":[0.9957774,0.00002901268,0.001070373,0.002467809,0.0002324328,0.0004229886],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001552529,0.0006052016,0.000001018756,0.002393041,0.0003808665,0.000002643135,0.00001565981,2.017742e-7,0.001105456,0.00001191662,0.2189704,0.7763584],"study_design_scores_gemma":[0.0009516427,0.001219752,3.241861e-7,0.02803245,0.0001458209,0.000008838409,0.000004758779,0.000001665739,0.00336599,0.00001291655,0.9652947,0.0009611099],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00001254613,0.9892749,0.00005502081,0.0002087107,0.006197838,0.00314669,0.0009566157,0.00007695684,0.00007074735],"genre_scores_gemma":[0.00001288793,0.9746252,0.0001511017,0.002271107,0.002494554,0.001829638,0.01689618,0.0002608507,0.00145847],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.7753972,"threshold_uncertainty_score":0.9994169,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2020159664","doi":"10.1517/13543776.2010.533171","title":"Diabetes area participation analysis: a review of companies and targets described in the 2008 – 2010 patent literature","year":2010,"lang":"en","type":"review","venue":"Expert Opinion on Therapeutic Patents","topic":"Natural Antidiabetic Agents Studies","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"University of Calgary; F. Hoffmann-La Roche","keywords":"Medicine; Diabetes mellitus; Type 2 diabetes; Macrovascular disease; Insulin resistance; Glycemic; Insulin; Disease; Diabetic retinopathy; Nephropathy; Retinopathy; Obesity; Internal medicine; Endocrinology; Intensive care medicine","authors":[{"name":"Philip A. Carpino","is_ca":false},{"name":"Bryan Goodwin","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.161926584440197,"gpt":0.3811564945442865,"spread":0.2192299101040895,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005799929,0.000573984,0.002640234,0.0003982922,0.00009098925,0.00003006246,0.000268528,0.0003235098,0.00005218961],"category_scores_gemma":[0.0001331272,0.0002916213,0.0006117679,0.001122826,0.0001574719,0.0000632517,0.00007362472,0.0007821861,0.00001059536],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004955644,"about_ca_system_score_gemma":0.00005188303,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001240354,"about_ca_topic_score_gemma":0.0000027077,"domain_scores_codex":[0.9969292,0.0005323228,0.001021325,0.0005163169,0.0006004969,0.0004003058],"domain_scores_gemma":[0.9982281,0.000266234,0.0005881788,0.0006341548,0.0001903073,0.00009300458],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00004683311,0.0009246894,0.002817791,0.03570313,0.003354005,0.00001558691,0.001912876,1.934808e-7,0.0000237162,0.0000394964,0.002028214,0.9531335],"study_design_scores_gemma":[0.0008841226,0.0003841165,0.01388646,0.1840454,0.00236398,0.00001245326,0.00008515764,0.00005173639,0.00002379052,0.00003702188,0.7977059,0.0005198966],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0003353998,0.9962379,0.000003688049,0.0008553155,0.0005622059,0.001891344,0.00006170313,0.0000229532,0.00002950859],"genre_scores_gemma":[0.002874713,0.9938623,0.00006005901,0.00181861,0.0001057238,0.0004509411,0.0007497451,0.00003339684,0.00004447098],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9526136,"threshold_uncertainty_score":0.9999536,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1989556851","doi":"10.1517/13543770903059125","title":"The search for new COX-2 inhibitors: a review of 2002 – 2008 patents","year":2009,"lang":"en","type":"review","venue":"Expert Opinion on Therapeutic Patents","topic":"Inflammatory mediators and NSAID effects","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"Fundação de Amparo à Pesquisa do Estado de Minas Gerais; Merck Canada; Conselho Nacional de Desenvolvimento Científico e Tecnológico","keywords":"Naproxen; Valdecoxib; Celecoxib; Medicine; Ibuprofen; Pharmacology; Inflammation; Cyclooxygenase; Nabumetone; Aspirin; Etoricoxib; Nonsteroidal; Chemistry; Enzyme; Rofecoxib; Internal medicine; Biochemistry","authors":[{"name":"Teodorico C. Ramalho","is_ca":false},{"name":"Marcus VJ Rocha","is_ca":false},{"name":"Elaine FF da Cunha","is_ca":false},{"name":"Matheus P. Freitas","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1324520550520304,"gpt":0.4087917491154659,"spread":0.2763396940634354,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00108579,0.0007551081,0.00254317,0.0002089241,0.0002097867,0.00002620613,0.0004835394,0.0004677392,0.0001152097],"category_scores_gemma":[0.0001561438,0.0004290496,0.001274994,0.0004043567,0.0001064996,0.00004409764,0.00005681451,0.0005581232,0.0001886722],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002214402,"about_ca_system_score_gemma":0.0008121607,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001756422,"about_ca_topic_score_gemma":3.062051e-7,"domain_scores_codex":[0.9957235,0.0004961372,0.001403973,0.0006257436,0.001018595,0.0007320367],"domain_scores_gemma":[0.9970599,0.0005453213,0.0006808031,0.001062951,0.0002623999,0.0003886419],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001287736,0.0001931819,0.000004074918,0.02749236,0.0003495834,0.000007071746,0.00007274914,3.842401e-8,0.000004441027,0.00003976029,0.06532793,0.90638],"study_design_scores_gemma":[0.001212083,0.0009546479,0.00001188642,0.1849595,0.0001578083,0.00003387637,0.000007519921,0.000005316263,0.00009456919,0.00001150824,0.8122378,0.0003135121],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.000001249801,0.9903876,0.00003330669,0.0007756657,0.002745703,0.005725929,0.00005167639,0.00005904885,0.0002197848],"genre_scores_gemma":[0.000003466412,0.9938167,0.00005243629,0.002345138,0.001676704,0.0004858414,0.0003057053,0.000131774,0.001182262],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9060665,"threshold_uncertainty_score":0.9998161,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2173701041","doi":"10.1517/13543776.2016.1115836","title":"Transglutaminase inhibitors: a patent review","year":2015,"lang":"en","type":"review","venue":"Expert Opinion on Therapeutic Patents","topic":"Blood properties and coagulation","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Ottawa","funders":"","keywords":"Tissue transglutaminase; Deamidation; Glutamine; Enzyme; Disease; GTP'; Cancer; Biochemistry; Pharmacology; Chemistry; Medicine; Biology; Cancer research; Amino acid; Internal medicine","authors":[{"name":"Jeffrey W. Keillor","is_ca":true},{"name":"Kim Yang-Ping Apperley","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.3485761927403397,"gpt":0.4178338653797347,"spread":0.06925767263939497,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004300826,0.0007324339,0.002451782,0.0001832117,0.00008165344,0.00002841825,0.0002363984,0.0004320857,0.0002346347],"category_scores_gemma":[0.00002259805,0.0004663026,0.0008758274,0.0004021177,0.00005416117,0.00007241215,0.00004385913,0.0005061894,0.0006464455],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002842532,"about_ca_system_score_gemma":0.0003675369,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002114166,"about_ca_topic_score_gemma":1.496521e-7,"domain_scores_codex":[0.9966414,0.0003572229,0.001044915,0.0006878547,0.0008325643,0.0004360391],"domain_scores_gemma":[0.998229,0.00003417118,0.0003743994,0.000851145,0.0001704775,0.0003408199],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0000634521,0.0003815607,0.000001629984,0.01654271,0.0003074053,0.00001585411,0.00009522427,5.364107e-8,0.000001149311,0.00001492638,0.00664153,0.9759345],"study_design_scores_gemma":[0.0008395152,0.0007254511,0.000002767184,0.1522591,0.0003347262,0.000107339,0.00001483597,0.000007956189,0.000005213516,0.00001091545,0.8452793,0.0004128155],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[7.804944e-7,0.9941864,0.00001678561,0.0006725633,0.001565896,0.002834124,0.00002613774,0.0001386343,0.000558686],"genre_scores_gemma":[0.00001926778,0.9932514,0.00003478553,0.003939505,0.0007962238,0.0006315061,0.0006607588,0.0001478774,0.0005186761],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9755217,"threshold_uncertainty_score":0.9997789,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1769626824","doi":"10.1517/13543776.12.4.513","title":"Recent progress in 5-HT<sub>6</sub>receptor antagonists for the treatment of CNS diseases","year":2002,"lang":"en","type":"article","venue":"Expert Opinion on Therapeutic Patents","topic":"Neurotransmitter Receptor Influence on Behavior","field":"Neuroscience","cited_by":35,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Discovery Centre","funders":"","keywords":"Serotonergic; Medicine; Mechanism (biology); 5-HT6 receptor; Schizophrenia (object-oriented programming); Neuroscience; Intensive care medicine; Pharmacology; Psychiatry; 5-HT receptor; Psychology; Receptor; Serotonin; Internal medicine; Epistemology; Philosophy","authors":[{"name":"Abdelmalik Slassi","is_ca":true},{"name":"Methvin Isaac","is_ca":true},{"name":"Anne O’Brien","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1194992108277012,"gpt":0.3431025908647595,"spread":0.2236033800370584,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00005957716,0.0003494458,0.0003238987,0.0001332974,0.0001771137,0.00005325114,0.0004513143,0.00007950184,0.000135172],"category_scores_gemma":[0.00002228302,0.0002337001,0.00019843,0.0003309259,0.0002669508,0.0001359041,0.00001837143,0.00009448835,0.0001158161],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001663496,"about_ca_system_score_gemma":0.00002189651,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000003777365,"about_ca_topic_score_gemma":8.181381e-7,"domain_scores_codex":[0.9976973,0.0002178476,0.0004573152,0.0006331628,0.0004896097,0.0005047532],"domain_scores_gemma":[0.9988041,0.0002984047,0.0001789003,0.0005490881,0.00004459118,0.0001249164],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0003289137,0.003402305,0.0072396,0.000009829423,0.00001578241,0.000004410558,0.001333655,0.000007791472,0.2989382,0.00005043319,0.0002377375,0.6884313],"study_design_scores_gemma":[0.002527419,0.001513617,0.01138007,0.00007319765,0.000008511738,0.000004342498,0.00005015711,0.000403145,0.8669581,0.00002628187,0.1167717,0.0002834587],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9756405,0.01421918,0.00003502471,0.003548292,0.002820173,0.003353795,0.0002288995,0.0001309831,0.00002317506],"genre_scores_gemma":[0.9415299,0.05535981,0.00002420575,0.001212167,0.0001206372,0.001650052,0.00001088997,0.00006127591,0.00003103211],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.6881478,"threshold_uncertainty_score":0.9530011,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2010505546","doi":"10.1517/13543776.2011.593510","title":"Cyclooxygenase-2 inhibitors: a literature and patent review (2009 – 2010)","year":2011,"lang":"en","type":"review","venue":"Expert Opinion on Therapeutic Patents","topic":"Inflammatory mediators and NSAID effects","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Alberta Hospital; University of Alberta","funders":"","keywords":"Cyclooxygenase; Chemistry; Pharmacology; Medicine; Biochemistry; Enzyme","authors":[{"name":"Baker Jawabrah Al‐Hourani","is_ca":true},{"name":"Sai Kiran Sharma","is_ca":true},{"name":"Mavanur R. Suresh","is_ca":true},{"name":"Frank Wuest","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1377688192194239,"gpt":0.3557674840241276,"spread":0.2179986648047037,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004975087,0.001053547,0.002700182,0.0003416496,0.0001255847,0.00004649394,0.0002401025,0.0007606775,0.0001811713],"category_scores_gemma":[0.00008445723,0.0006770462,0.0007619514,0.0003891654,0.00009160435,0.0000794238,0.00009017022,0.0008990432,0.0003560781],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001451713,"about_ca_system_score_gemma":0.0002515389,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001165125,"about_ca_topic_score_gemma":2.802449e-7,"domain_scores_codex":[0.9964285,0.0004990937,0.00100595,0.0009277641,0.0005150252,0.0006236817],"domain_scores_gemma":[0.9977158,0.0001252739,0.0005258138,0.0009855744,0.0001316343,0.0005159272],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00006265724,0.0002406106,0.000009578467,0.03936208,0.0003569659,0.0001045624,0.0003091663,2.013187e-9,0.000004140814,0.00004309984,0.01427287,0.9452342],"study_design_scores_gemma":[0.000695803,0.0004944174,0.00002754893,0.2456425,0.0001936006,0.0002729103,0.000003644624,7.863835e-7,0.00001373043,0.00001581537,0.7521511,0.0004881155],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.000006731557,0.9926293,0.000003706326,0.0002145555,0.003729757,0.003024395,0.00007433055,0.000137461,0.0001797588],"genre_scores_gemma":[0.00000757211,0.9923183,0.00003841617,0.004282167,0.001324923,0.0006261482,0.0006706712,0.0001750066,0.0005568127],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9447461,"threshold_uncertainty_score":0.999568,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3081954160","doi":"10.1080/13543776.2020.1817390","title":"Inhibitors of type II transmembrane serine proteases in the treatment of diseases of the respiratory tract – A review of patent literature","year":2020,"lang":"en","type":"review","venue":"Expert Opinion on Therapeutic Patents","topic":"Liver physiology and pathology","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Université de Sherbrooke","funders":"Canadian Institutes of Health Research","keywords":"Proteases; TMPRSS2; Respiratory tract; Transmembrane protein; Serine; Biology; Medicine; Pharmacology; Respiratory system; Immunology; Enzyme; Receptor; Coronavirus disease 2019 (COVID-19); Biochemistry; Pathology; Disease; Internal medicine; Infectious disease (medical specialty)","authors":[{"name":"Alexandre Murza","is_ca":true},{"name":"Sébastien P. Dion","is_ca":true},{"name":"Pierre‐Luc Boudreault","is_ca":true},{"name":"Antoine Désilets","is_ca":true},{"name":"Richard Leduc","is_ca":true},{"name":"Éric Marsault","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1508476443493234,"gpt":0.3814635435339384,"spread":0.230615899184615,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001618484,0.0003709147,0.002145432,0.0001103079,0.00002835606,0.000001070474,0.0002934875,0.0002288625,0.00004200119],"category_scores_gemma":[0.00004187227,0.0001643988,0.0008148279,0.0005579913,0.0001973526,0.00002347669,0.00002384516,0.000234994,0.000001280675],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004082172,"about_ca_system_score_gemma":0.0002758442,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001126739,"about_ca_topic_score_gemma":1.303541e-7,"domain_scores_codex":[0.9971341,0.00105863,0.001031989,0.0003036013,0.0003203541,0.0001513048],"domain_scores_gemma":[0.9982332,0.0001726389,0.0007781995,0.0006555789,0.000112839,0.00004753468],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.001106764,0.008025639,0.0006626801,0.1212062,0.000921697,0.00003361584,0.004097023,6.699681e-7,0.0009161627,0.00006412814,0.0001509624,0.8628144],"study_design_scores_gemma":[0.002267442,0.01018801,0.00416334,0.2507744,0.0007229642,0.00003902037,0.00006705682,9.362129e-7,0.001255349,0.00003036921,0.7302465,0.0002445825],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.001345741,0.9949325,1.881386e-7,0.0002466268,0.0003467814,0.002871931,0.0002311787,0.000006456779,0.0000185947],"genre_scores_gemma":[0.0123601,0.9865409,0.000004322924,0.000569951,0.0001096472,0.0002130852,0.0001656229,0.0000263915,0.00001001279],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.8625699,"threshold_uncertainty_score":0.6703987,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2466927139","doi":"10.1080/13543776.2016.1206080","title":"Proprotein convertase subtilisin / kexin 9 (PCSK9) inhibitors and the future of dyslipidemia therapy: an updated patent review (2011-2015)","year":2016,"lang":"en","type":"review","venue":"Expert Opinion on Therapeutic Patents","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Université de Montréal; Montreal Clinical Research Institute","funders":"Fondation Leducq","keywords":"PCSK9; Alirocumab; Evolocumab; Kexin; Proprotein convertase; Dyslipidemia; Medicine; Pharmacology; Monoclonal antibody; Cholesterol; LDL receptor; Antibody; Internal medicine; Immunology; Lipoprotein; Disease","authors":[{"name":"Sandy Elbitar","is_ca":false},{"name":"Petra El Khoury","is_ca":false},{"name":"Youmna Ghaleb","is_ca":false},{"name":"Jean‐Pierre Rabès","is_ca":false},{"name":"Mathilde Varret","is_ca":false},{"name":"Nabil G. Seidah","is_ca":true},{"name":"Cathérine Boileau","is_ca":false},{"name":"Marianne Abifadel","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.08188793832644997,"gpt":0.3603073481168442,"spread":0.2784194097903943,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.002793901,0.001043537,0.004231293,0.0002239696,0.0001840932,0.00003248457,0.000493785,0.0007015133,0.0005148406],"category_scores_gemma":[0.00003535756,0.0004685302,0.001392045,0.0002733706,0.0003894324,0.0001295995,0.000105397,0.0007916604,0.0001182161],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002027106,"about_ca_system_score_gemma":0.0005779772,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001421914,"about_ca_topic_score_gemma":0.00000179406,"domain_scores_codex":[0.9928669,0.002415459,0.001728631,0.001081745,0.001263208,0.0006440197],"domain_scores_gemma":[0.9957718,0.000102885,0.001093691,0.002301323,0.0002959144,0.0004343719],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0005709112,0.0002853962,0.000008512243,0.008240288,0.001086024,0.000009889593,0.0001385319,8.606741e-9,0.000009612322,0.0001475664,0.00279816,0.9867051],"study_design_scores_gemma":[0.005230188,0.0007805369,0.00003338528,0.05146978,0.0002456456,0.00008790877,0.00004413003,0.000002822119,0.00007980965,0.00004589388,0.9414789,0.0005010023],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00003268545,0.9858541,0.00002030571,0.002745249,0.001743748,0.009362099,0.0001021481,0.00009113614,0.00004845729],"genre_scores_gemma":[0.0001224274,0.9921029,0.00003511239,0.003765591,0.001823446,0.001151257,0.0006651643,0.0001828215,0.0001513227],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9862041,"threshold_uncertainty_score":0.9997767,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2084903264","doi":"10.1517/13543776.17.4.371","title":"Metabotropic glutamate receptor 5 modulators and their potential therapeutic applications","year":2007,"lang":"en","type":"article","venue":"Expert Opinion on Therapeutic Patents","topic":"Neuroscience and Neuropharmacology Research","field":"Neuroscience","cited_by":23,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Toronto Public Health","funders":"AstraZeneca","keywords":"Metabotropic glutamate receptor; Metabotropic glutamate receptor 5; Neuroscience; Metabotropic receptor; Metabotropic glutamate receptor 2; Glutamate receptor; Receptor; Class C GPCR; Metabotropic glutamate receptor 1; Metabotropic glutamate receptor 7; Pharmacology; Biology; Biochemistry","authors":[{"name":"Peter Bach","is_ca":false},{"name":"Methvin Isaac","is_ca":true},{"name":"Abdelmalik Slassi","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.08032992125195253,"gpt":0.3618215717416292,"spread":0.2814916504896767,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003420001,0.0003192068,0.0002508325,0.0002606384,0.0005795848,0.00009399491,0.0005527519,0.0001096865,0.0001173726],"category_scores_gemma":[0.00002397701,0.000237888,0.0001028186,0.0005325031,0.0004080997,0.000216161,0.0001237229,0.000354861,0.000225318],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004266399,"about_ca_system_score_gemma":0.00003509336,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000003882714,"about_ca_topic_score_gemma":1.158259e-7,"domain_scores_codex":[0.9972633,0.000325235,0.000331608,0.0008662208,0.0004828965,0.0007308125],"domain_scores_gemma":[0.9988783,0.0002614894,0.0001147392,0.0004410901,0.0000424305,0.0002619569],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0001954792,0.0002690029,0.0001979529,0.00000429253,0.00001198228,0.000007090801,0.0001868755,0.00000701938,0.9257023,0.001291434,0.00003636576,0.0720902],"study_design_scores_gemma":[0.001004133,0.0003921392,0.004035633,0.000008926981,0.000003261248,0.00004288558,0.00007901691,0.000797407,0.9275649,0.00105358,0.06470197,0.0003161557],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9782436,0.004108701,0.009037756,0.001620638,0.00411931,0.001864049,0.00003814075,0.0004120139,0.0005557956],"genre_scores_gemma":[0.9866878,0.005372121,0.00002056854,0.007335749,0.0002513493,0.0001277153,0.000001812457,0.00004875243,0.0001541024],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.07177404,"threshold_uncertainty_score":0.9700791,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2156817850","doi":"10.1517/13543776.16.7.977","title":"TRPV1 antagonists: a survey of the patent literature","year":2006,"lang":"en","type":"article","venue":"Expert Opinion on Therapeutic Patents","topic":"Ion Channels and Receptors","field":"Neuroscience","cited_by":22,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Purdue Pharma (Canada)","funders":"","keywords":"TRPV1; Pharmacology; Medicine; Clinical trial; Computational biology; Business; Biology; Receptor; Internal medicine; Transient receptor potential channel","authors":[{"name":"Donald J. Kyle","is_ca":true},{"name":"Laykea Tafesse","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1222570584195841,"gpt":0.3083448457455742,"spread":0.1860877873259901,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000186865,0.0002070237,0.0001949581,0.00006526081,0.0001982566,0.00005085621,0.0004218758,0.0001140005,0.00006065092],"category_scores_gemma":[0.00004586388,0.0001156783,0.0001378459,0.000401033,0.0001246839,0.00007154699,0.00005914019,0.0001749091,0.00003445338],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004014384,"about_ca_system_score_gemma":0.00002922208,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002825075,"about_ca_topic_score_gemma":0.000003350801,"domain_scores_codex":[0.9981031,0.0004616485,0.0003139573,0.0003667472,0.0004703767,0.0002841806],"domain_scores_gemma":[0.9992791,0.0001149956,0.0001738212,0.0003172311,0.00006951005,0.00004530884],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0005184903,0.001947365,0.01143773,0.00003517559,0.0000356208,0.00000797277,0.002358221,0.0002162471,0.9503678,0.003849259,0.008774337,0.02045176],"study_design_scores_gemma":[0.00111081,0.0001845598,0.07784609,0.0002067431,0.000001339272,0.00001233234,0.0000356782,0.0004000927,0.8935774,0.0006345623,0.02570167,0.0002887166],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9665974,0.007726748,0.0001931773,0.002668049,0.01917282,0.001212713,0.0003504867,0.0001854125,0.001893163],"genre_scores_gemma":[0.9965706,0.001191929,0.000006937473,0.001436318,0.0001756508,0.00002085256,0.00002473777,0.00002588163,0.0005470462],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.06640837,"threshold_uncertainty_score":0.4717225,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2018494913","doi":"10.1517/13543776.2014.851669","title":"An overview of patented small molecule stearoyl coenzyme-A desaturase inhibitors (2009 – 2013)","year":2013,"lang":"en","type":"review","venue":"Expert Opinion on Therapeutic Patents","topic":"Fatty Acid Research and Health","field":"Nursing","cited_by":19,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Aboriginal Affairs Northern Dev Canada","funders":"Glenmark Pharmaceuticals; Pfizer","keywords":"Adverse effect; Pharmacology; Medicine; Small molecule; Fatty liver; Bioinformatics; Biology; Cancer research; Biochemistry; Internal medicine","authors":[{"name":"David Powell","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.27537770642034,"gpt":0.4409548434803954,"spread":0.1655771370600554,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005852445,0.0009874917,0.002239822,0.0006060062,0.0002455461,0.000116676,0.001020686,0.0007713267,0.0003902037],"category_scores_gemma":[0.00004995913,0.0007380743,0.0007345597,0.0006208769,0.0001792703,0.0002096627,0.0001110659,0.001074692,0.0006997753],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003758022,"about_ca_system_score_gemma":0.0002793035,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001225889,"about_ca_topic_score_gemma":0.00001152088,"domain_scores_codex":[0.9937077,0.00154184,0.001462124,0.001046265,0.001026374,0.001215653],"domain_scores_gemma":[0.9964692,0.0002111075,0.0008781059,0.001442728,0.0002743572,0.000724485],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0002058147,0.001018054,0.00001011197,0.005871814,0.000224722,0.000008823502,0.0002596381,9.343423e-7,0.0003703004,0.00004041603,0.0129167,0.9790727],"study_design_scores_gemma":[0.00128005,0.002233378,0.00003977494,0.02140965,0.00005403929,0.00001989156,0.00009008932,0.000109793,0.001954535,0.00004784343,0.9719099,0.0008510706],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00009078462,0.993104,0.00004289249,0.0003179731,0.003206486,0.002861996,0.0001742932,0.0001554097,0.00004611466],"genre_scores_gemma":[0.0001408415,0.9964692,0.0003070004,0.001023718,0.0004861206,0.000362712,0.0009303989,0.000229868,0.00005015857],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9782216,"threshold_uncertainty_score":0.999507,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2020008986","doi":"10.1517/13543776.12.8.1215","title":"Gangliosides: therapeutic agents or therapeutic targets?","year":2002,"lang":"en","type":"article","venue":"Expert Opinion on Therapeutic Patents","topic":"Glycosylation and Glycoproteins Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":14,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McGill University","funders":"","keywords":"Neurodegeneration; Drug; Computational biology; Glycolipid; Drug discovery; Biology; Neuroscience; Pharmacology; Medicine; Immunology; Bioinformatics; Disease","authors":[{"name":"H. Uri Saragovi","is_ca":true},{"name":"Martin Gagnon","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.110599248225029,"gpt":0.3483887617806951,"spread":0.2377895135556661,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0002426182,0.0004558364,0.0002989826,0.000181829,0.0003022492,0.0001004145,0.0005819891,0.0003063468,0.003592068],"category_scores_gemma":[0.00004577645,0.0003444224,0.0002210965,0.0003097461,0.0001343219,0.0000177347,0.0001046773,0.0002558508,0.0008644164],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00006354736,"about_ca_system_score_gemma":0.00004736114,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001931465,"about_ca_topic_score_gemma":0.00000478143,"domain_scores_codex":[0.9970647,0.0003180536,0.0004231444,0.0007717247,0.0006812635,0.0007411643],"domain_scores_gemma":[0.998556,0.00004036406,0.0001374072,0.0008789728,0.0001408395,0.0002464725],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.002548223,0.00274502,0.002785334,0.00005508754,0.001156156,0.00005506236,0.001891097,0.000130778,0.3633942,0.0007822239,0.0327024,0.5917544],"study_design_scores_gemma":[0.00329553,0.002018839,0.003361629,0.00006475733,0.000008112932,0.00004362413,0.0003011921,0.002484848,0.09337331,0.0002781451,0.8939824,0.0007876055],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"empirical","genre_scores_codex":[0.3110663,0.5016664,0.03891773,0.03238607,0.02263851,0.01872907,0.0004402556,0.002078267,0.07207736],"genre_scores_gemma":[0.9721002,0.01213521,0.0001094204,0.008624076,0.0004753182,0.0002240051,0.0001247295,0.0001055984,0.006101425],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.86128,"threshold_uncertainty_score":0.9999135,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2137798595","doi":"10.1517/13543771003702432","title":"Novel substituted heteroaromatic compounds as inhibitors of stearoyl-CoA desaturase","year":2010,"lang":"en","type":"article","venue":"Expert Opinion on Therapeutic Patents","topic":"Fatty Acid Research and Health","field":"Nursing","cited_by":11,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Steatosis; Pharmacology; Medicine; Disease; Metabolic syndrome; Diabetes mellitus; Chemistry; Bioinformatics; Biochemistry; Biology; Internal medicine; Endocrinology","authors":[{"name":"Paweł Dobrzyń","is_ca":false},{"name":"Agnieszka Dobrzyń","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.0652826197250013,"gpt":0.3566787178923051,"spread":0.2913960981673038,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000333126,0.0002745547,0.0003583099,0.0002442444,0.0002397182,0.00005493817,0.0003730139,0.0002101697,0.0001349348],"category_scores_gemma":[0.00008549234,0.0002262957,0.0001417061,0.0002669954,0.0002312918,0.0001729416,0.00004848406,0.0005992713,0.0002054715],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00008827526,"about_ca_system_score_gemma":0.00007587422,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005679037,"about_ca_topic_score_gemma":0.00002715823,"domain_scores_codex":[0.9976583,0.0001422257,0.0004983446,0.0003790049,0.0007395954,0.0005825497],"domain_scores_gemma":[0.9986505,0.0001686236,0.0001914768,0.0005677587,0.0001142287,0.000307394],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0009002392,0.0008910671,0.001350242,0.00006111204,0.00005634078,0.000002808662,0.001381169,0.000005501553,0.9759299,0.0002678167,0.0007209991,0.01843287],"study_design_scores_gemma":[0.005991299,0.00169186,0.03084902,0.0005078184,0.00000704804,0.00004832729,0.0004756859,0.001509473,0.9411133,0.0006389455,0.01657925,0.0005879476],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9882644,0.0007842003,0.0001853885,0.002471678,0.006911543,0.0007107829,0.00002382409,0.0001414505,0.000506702],"genre_scores_gemma":[0.99695,0.0001467826,0.001045839,0.00138404,0.0002952901,0.00003740192,0.00006632941,0.00004860685,0.00002574306],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.03481651,"threshold_uncertainty_score":0.9228072,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2031439958","doi":"10.1517/13543776.11.4.625","title":"Novel serotonergic and non-serotonergic migraine headache therapies","year":2001,"lang":"en","type":"article","venue":"Expert Opinion on Therapeutic Patents","topic":"Migraine and Headache Studies","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"IDELIX Software (Canada)","funders":"","keywords":"Sumatriptan; Migraine; Rizatriptan; Zolmitriptan; Triptans; Medicine; Serotonergic; Pharmacology; Methysergide; Intensive care medicine; Neuroscience; Serotonin; Psychology; Agonist; Anesthesia; Internal medicine; Receptor","authors":[{"name":"Abdelmalik Slassi","is_ca":true},{"name":"Methvin Isaac","is_ca":true},{"name":"Jalaj Arora","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.0809376976532069,"gpt":0.3430766452850072,"spread":0.2621389476318003,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002119297,0.0004340899,0.0005778458,0.0001863647,0.0002639474,0.0000330962,0.0001362305,0.0001656058,0.0002076747],"category_scores_gemma":[0.00001930075,0.0003171048,0.0001931963,0.0002743463,0.0001636293,0.00009601771,0.00006344102,0.0002804181,0.0000752449],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00005900799,"about_ca_system_score_gemma":0.00004362914,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002712146,"about_ca_topic_score_gemma":0.00001351398,"domain_scores_codex":[0.9980128,0.00005227006,0.0003968303,0.0005479095,0.0004612887,0.000528852],"domain_scores_gemma":[0.9990054,0.0000794859,0.0001059231,0.000478721,0.0001010192,0.0002294446],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","study_design_scores_codex":[0.008753123,0.00844536,0.2160414,0.0004406977,0.004677537,0.0002153278,0.04897228,0.00002147177,0.5317746,0.003062423,0.05349509,0.1241007],"study_design_scores_gemma":[0.01222523,0.002985839,0.2565321,0.0006725601,0.00004711652,0.0004390189,0.003486516,0.0008418405,0.007685843,0.0003645195,0.7137531,0.0009663637],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9079337,0.05518878,0.001109904,0.0244258,0.0004303228,0.002531478,0.0000183502,0.0003631456,0.007998495],"genre_scores_gemma":[0.9595048,0.02514143,0.0004762239,0.009706989,0.0004867753,0.0002743648,0.00004519897,0.00006919428,0.00429505],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.660258,"threshold_uncertainty_score":0.9999281,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1993341051","doi":"10.1517/13543776.12.12.1795","title":"Developments in mitogen-induced extracellular kinase 1 inhibitors and their use in the treatment of disease","year":2002,"lang":"en","type":"article","venue":"Expert Opinion on Therapeutic Patents","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":9,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"St. Joseph’s Healthcare Hamilton; McMaster University; St. Joseph's Hospital; University of Toronto","funders":"","keywords":"MAPK/ERK pathway; Kinase; Signal transduction; Cancer research; Extracellular; Protein kinase A; Mitogen-activated protein kinase; Immune system; ASK1; Biology; Cell biology; Medicine; Immunology; Mitogen-activated protein kinase kinase","authors":[{"name":"Joan C. Krepinsky","is_ca":true},{"name":"Dongcheng Wu","is_ca":true},{"name":"Alistair J. Ingram","is_ca":true},{"name":"James W. Scholey","is_ca":true},{"name":"Damu Tang","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.08536307861861339,"gpt":0.2744875942477289,"spread":0.1891245156291156,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007261688,0.0001805352,0.0001383935,0.00006765675,0.00003598754,0.0000136675,0.0001086871,0.00008060806,0.000006918049],"category_scores_gemma":[0.000008615671,0.0001149409,0.00005320706,0.00007732253,0.0000304647,0.000005820984,0.00001710208,0.00003909803,0.000003673096],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0000253534,"about_ca_system_score_gemma":0.00001577802,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0000534877,"about_ca_topic_score_gemma":0.0000125107,"domain_scores_codex":[0.9990661,0.0001404339,0.0002194578,0.000276716,0.0001081822,0.0001891532],"domain_scores_gemma":[0.9995669,0.0000214033,0.00005581856,0.0002786004,0.00001388075,0.0000633853],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0004485704,0.002101136,0.0567137,0.00001256945,0.00006518504,0.00001806777,0.00651153,0.000005407533,0.8114421,0.00007476199,0.00009949125,0.1225075],"study_design_scores_gemma":[0.005654291,0.002279922,0.1283237,0.0001423895,0.000004644314,0.000006740713,0.001143295,0.0002182102,0.7339102,0.00005324532,0.1277322,0.0005311389],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9868935,0.01230435,0.00001037234,0.00007909547,0.0003103621,0.0003421694,0.00001049633,0.000003806202,0.00004580148],"genre_scores_gemma":[0.9930244,0.006458093,0.00001855467,0.0002173401,0.00005959135,0.00008486629,0.00004683531,0.00001416909,0.00007616086],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1276327,"threshold_uncertainty_score":0.4687154,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4386945206","doi":"10.1080/13543776.2023.2262136","title":"Type I inhibitors of tropomyosin receptor kinase (Trk): a 2020–2022 patent update","year":2023,"lang":"en","type":"review","venue":"Expert Opinion on Therapeutic Patents","topic":"Protein Degradation and Inhibitors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":9,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"TRIUMF; University of British Columbia; University of Alberta","funders":"","keywords":"Trk receptor; Medicine; Precision medicine; Pharmacology; Bioinformatics; Cancer research; Computational biology; Biology; Receptor; Internal medicine; Neurotrophin; Pathology","authors":[{"name":"Carolin Jaworski","is_ca":true},{"name":"Petar Iliev","is_ca":true},{"name":"Carmen Wängler","is_ca":false},{"name":"Björn Wängler","is_ca":false},{"name":"Brent D. G. Page","is_ca":true},{"name":"Ralf Schirrmacher","is_ca":true},{"name":"Justin J. Bailey","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1103937892736046,"gpt":0.3584458892396905,"spread":0.2480520999660859,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002811658,0.000608758,0.0009730664,0.0002067085,0.00009795088,0.00003112999,0.0005096289,0.0005768192,0.00019541],"category_scores_gemma":[0.00007591548,0.0004928819,0.0005946186,0.0005103305,0.0001015904,0.000006848461,0.0002115626,0.0002959396,0.000481165],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00008824098,"about_ca_system_score_gemma":0.000238132,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002350539,"about_ca_topic_score_gemma":0.000001055277,"domain_scores_codex":[0.9969854,0.0004120122,0.0009265413,0.000808672,0.0004589722,0.000408432],"domain_scores_gemma":[0.9982476,0.00002581086,0.0006017953,0.0008301432,0.0001320394,0.0001626089],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001724974,0.0003371388,0.000005343734,0.0009379995,0.0005111337,0.000004220737,0.00004680745,9.946278e-7,0.005833324,0.00008690486,0.03338318,0.9586805],"study_design_scores_gemma":[0.000506976,0.0006497138,0.000002370254,0.00279868,0.00002627678,0.000005170683,0.00003112226,0.000002829586,0.01101369,0.000016286,0.9844499,0.0004969442],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001449085,0.9942179,0.00002121457,0.0001109674,0.004189871,0.001024875,0.0001603149,0.0000586768,0.00007121069],"genre_scores_gemma":[0.0001411974,0.9942414,0.00006347305,0.0003116479,0.0008621452,0.0002460333,0.003028705,0.0001581471,0.0009472123],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9581835,"threshold_uncertainty_score":0.9997523,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1967410304","doi":"10.1517/13543776.2015.1010512","title":"Phosphorus-containing nanoparticles: biomedical patents review","year":2015,"lang":"en","type":"review","venue":"Expert Opinion on Therapeutic Patents","topic":"Nanoparticle-Based Drug Delivery","field":"Materials Science","cited_by":7,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Calgary","funders":"","keywords":"Nanotechnology; Phosphorus; Nanoparticle; Chemistry; Business; Materials science; Organic chemistry","authors":[{"name":"Dzmitry Shcharbin","is_ca":false},{"name":"Natallia Shcharbina","is_ca":false},{"name":"Antos Shakhbazau","is_ca":true},{"name":"Serge Mignani","is_ca":false},{"name":"Jean‐Pierre Majoral","is_ca":false},{"name":"Maria Bryszewska","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1421158192122157,"gpt":0.379793716350022,"spread":0.2376778971378063,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001933787,0.00107084,0.002780486,0.0002423846,0.0002225589,0.0001473089,0.001350575,0.000474102,0.0006600137],"category_scores_gemma":[0.0001587977,0.0007867206,0.0006336049,0.0007979801,0.0002623924,0.0002649223,0.0003079058,0.0004992569,0.008551945],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000647029,"about_ca_system_score_gemma":0.0006777587,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00004891741,"about_ca_topic_score_gemma":1.826275e-7,"domain_scores_codex":[0.9925926,0.001228472,0.001829068,0.001373622,0.001761594,0.001214682],"domain_scores_gemma":[0.9964946,0.0002594208,0.0008789678,0.001436729,0.0002194759,0.0007108449],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00007876107,0.0006030778,0.000003646064,0.003219019,0.0001198892,0.00004856682,0.0001555728,3.889264e-7,0.0007812503,0.00004706408,0.007128306,0.9878145],"study_design_scores_gemma":[0.0008516594,0.0005920751,0.000001004647,0.05218355,0.0001187064,0.00004346677,0.00003674597,0.00001829245,0.0008833527,0.00003997659,0.9443877,0.0008434593],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001009155,0.9922126,0.00002527828,0.0002102269,0.005101702,0.001781951,0.0001219466,0.0003402957,0.0001050943],"genre_scores_gemma":[0.000208079,0.9948289,0.0001287175,0.003082938,0.0004563848,0.0007438228,0.0002738819,0.0001881899,0.0000890312],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.986971,"threshold_uncertainty_score":0.9994584,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1969226240","doi":"10.1517/13543776.12.8.1237","title":"Novel therapeutic strategies for impaired endothelium-dependent vascular relaxation","year":2002,"lang":"en","type":"article","venue":"Expert Opinion on Therapeutic Patents","topic":"Eicosanoids and Hypertension Pharmacology","field":"Biochemistry, Genetics and Molecular Biology","cited_by":6,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Saskatchewan","funders":"","keywords":"Endothelium; Pharmacology; Medicine; Vascular smooth muscle; Endothelial dysfunction; Angiogenesis; Fibrinolysis; Angiotensin II; Platelet; Immunology; Internal medicine; Blood pressure","authors":[{"name":"Rui Wang","is_ca":true},{"name":"Joseph Fomusi Ndisang","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.07753051824902753,"gpt":0.3153465721417966,"spread":0.2378160538927691,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001798379,0.0002988204,0.0002422183,0.00007747146,0.000198869,0.00005185548,0.0002674602,0.0002411032,0.0001757287],"category_scores_gemma":[0.00001420612,0.0002495739,0.0002219727,0.00006777468,0.00006549352,0.00001432967,0.00004384619,0.0001126691,0.00005222537],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003050326,"about_ca_system_score_gemma":0.00003630345,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001515145,"about_ca_topic_score_gemma":0.000002123806,"domain_scores_codex":[0.9983878,0.0001011583,0.0003119957,0.0005474798,0.00024681,0.0004047683],"domain_scores_gemma":[0.9991711,0.00003268376,0.0001420562,0.0004291123,0.0001212887,0.0001037804],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0002247884,0.0005675564,0.0000773568,0.00000925501,0.0002727903,9.198458e-7,0.0002703899,0.000094395,0.9715186,0.0009241607,0.002305949,0.02373389],"study_design_scores_gemma":[0.01346779,0.004324404,0.00234542,0.00006580589,0.00005923237,0.00006197464,0.001102726,0.008694594,0.3673311,0.0014593,0.5996974,0.001390211],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.4848526,0.1751008,0.2942179,0.01101058,0.01856625,0.009482446,0.0005468276,0.0007720508,0.005450573],"genre_scores_gemma":[0.9854172,0.006205312,0.0003873649,0.00659407,0.0005551365,0.0001986906,0.0001466497,0.0000672787,0.0004282576],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.6041874,"threshold_uncertainty_score":0.9999956,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4398778278","doi":"10.1080/13543776.2024.2358818","title":"Type II &amp; III inhibitors of tropomyosin receptor kinase (Trk): a 2020–2022 patent update","year":2024,"lang":"en","type":"article","venue":"Expert Opinion on Therapeutic Patents","topic":"Protein Kinase Regulation and GTPase Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":5,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"TRIUMF; University of Alberta; University of British Columbia","funders":"","keywords":"Trk receptor; Tropomyosin; Receptor; Tropomyosin receptor kinase A; Chemistry; Tropomyosin receptor kinase C; Kinase; Biochemistry; Pharmacology; Cell biology; Biology; Platelet-derived growth factor receptor; Neurotrophin","authors":[{"name":"Petar Iliev","is_ca":true},{"name":"Carolin Jaworski","is_ca":true},{"name":"Carmen Wängler","is_ca":false},{"name":"Björn Wängler","is_ca":false},{"name":"Brent D. G. Page","is_ca":true},{"name":"Ralf Schirrmacher","is_ca":true},{"name":"Justin J. Bailey","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03968029780223813,"gpt":0.2999855850946541,"spread":0.2603052872924159,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002014787,0.0002495767,0.0002064178,0.0001000123,0.0001219098,0.00002988966,0.0001734773,0.000177301,0.0005014252],"category_scores_gemma":[0.0000190937,0.0002143281,0.0001742804,0.0002520033,0.00007182219,0.000008531885,0.00011026,0.0001290529,0.000090039],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004280124,"about_ca_system_score_gemma":0.00008473081,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002680714,"about_ca_topic_score_gemma":0.000001476571,"domain_scores_codex":[0.998451,0.0001224673,0.0003736162,0.0004859003,0.0003009837,0.0002660284],"domain_scores_gemma":[0.9992953,0.00000953386,0.00009872069,0.0003953743,0.00009086415,0.0001102276],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0004461607,0.0002009721,0.00004443506,0.00002611769,0.0001319522,0.000003038644,0.0002455916,0.00003807181,0.9398945,0.0003070645,0.007271866,0.05139022],"study_design_scores_gemma":[0.0006505323,0.0004470325,0.00006004447,0.0001726605,0.000004933147,0.000005245492,0.00004594077,0.0001511275,0.4863673,0.00008575688,0.5117794,0.0002299998],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8639159,0.1220096,0.002935648,0.002524996,0.006783312,0.001114788,0.0001197854,0.000177643,0.0004182673],"genre_scores_gemma":[0.9901471,0.006884142,0.0002765118,0.000692917,0.0005309861,0.00005551663,0.0006428538,0.000052967,0.0007170588],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5045075,"threshold_uncertainty_score":0.8740045,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2590797524","doi":"10.1080/13543776.2017.1296950","title":"Patent disclosure requirements for therapeutic antibody patents","year":2017,"lang":"en","type":"review","venue":"Expert Opinion on Therapeutic Patents","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":4,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Business; Antibody; Pharmacology; Medicine; Immunology","authors":[{"name":"Carmela De Luca","is_ca":false},{"name":"Anastassia Trifonova","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.6197336892953145,"gpt":0.4823808556046756,"spread":0.1373528336906388,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0009184917,0.001252009,0.003405587,0.0005530439,0.0006277544,0.0004413269,0.001836368,0.0007814199,0.0004006216],"category_scores_gemma":[0.0000575287,0.001135077,0.001744576,0.0001627538,0.0001701164,0.0003283029,0.0002383182,0.0006014791,0.002363559],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005254365,"about_ca_system_score_gemma":0.0001329622,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00006059772,"about_ca_topic_score_gemma":0.000001154633,"domain_scores_codex":[0.99441,0.0001335354,0.002305696,0.001689679,0.0001638075,0.001297237],"domain_scores_gemma":[0.9951449,0.0001802049,0.002325784,0.001860805,0.00006574467,0.0004225643],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00009060725,0.0006695057,0.0001839387,0.001596354,0.001629845,0.000004093841,0.0001473733,0.000001480955,0.000001900301,0.02627217,0.001723072,0.9676797],"study_design_scores_gemma":[0.001786007,0.000328142,0.0001096586,0.002313689,0.00005720701,0.000006558915,0.000007216374,0.000238632,0.000003810381,0.01060068,0.9832892,0.001259211],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00000511699,0.9829252,0.0005893063,0.0006519758,0.007251095,0.002783108,0.002075584,0.0001003044,0.003618248],"genre_scores_gemma":[0.0008302905,0.9915394,0.00005447129,0.002671754,0.001149572,0.001092731,0.001355579,0.000322109,0.0009841014],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9815661,"threshold_uncertainty_score":0.9991099,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2762459231","doi":"10.1080/13543776.2018.1388780","title":"Bill C-30: who wins and who loses in Canada’s pharmaceutical patent battles?","year":2017,"lang":"en","type":"editorial","venue":"Expert Opinion on Therapeutic Patents","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":3,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"University of Calgary","funders":"","keywords":"Business; Patent analysis; Patent troll; Patent law; Law; Political science; Computer science; Intellectual property","authors":[{"name":"Aidan Hollis","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1481829467643043,"gpt":0.340395631864411,"spread":0.1922126851001068,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005493516,0.00073313,0.001445269,0.0003574346,0.0002475207,0.0002723498,0.0009233255,0.000882053,0.0006715266],"category_scores_gemma":[0.0002106194,0.0006983092,0.0001906224,0.00008403948,0.0001765205,0.0002116446,0.0002604421,0.001514862,0.00035966],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001407211,"about_ca_system_score_gemma":0.0008904919,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.3520423,"about_ca_topic_score_gemma":0.02710923,"domain_scores_codex":[0.9962104,0.00008601048,0.001238591,0.001253369,0.0002197559,0.000991851],"domain_scores_gemma":[0.9974678,0.0004002851,0.0007207188,0.000868194,0.00005455868,0.0004884249],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0002362267,0.0002697769,0.006360121,0.00009764858,0.0003439672,0.00002989989,0.0003890077,0.00002262235,0.000004368391,0.003720942,0.9668192,0.02170626],"study_design_scores_gemma":[0.002473201,0.0001118237,0.003925816,0.0002590413,0.00000522475,0.000001696095,0.000023778,0.002227663,0.00003641045,0.002362896,0.9876928,0.0008795951],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"editorial","genre_gemma":"editorial","genre_scores_codex":[0.002953241,0.0511818,0.00002732872,0.008973849,0.9182047,0.001171979,0.004492517,0.00006134505,0.01293326],"genre_scores_gemma":[0.2103523,0.3631461,0.00003080716,0.01658454,0.4054464,0.0004016561,0.0008193824,0.0005129132,0.002705931],"genre_candidate":"editorial","genre_consensus":"editorial","teacher_disagreement_score":0.5127583,"threshold_uncertainty_score":0.9995468,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4402118985","doi":"10.1080/13543776.2024.2400175","title":"Trends in covalent drug discovery: a 2020–23 patent landscape analysis focused on select covalent reacting groups (CRGs) found in FDA-approved drugs","year":2024,"lang":"en","type":"review","venue":"Expert Opinion on Therapeutic Patents","topic":"Click Chemistry and Applications","field":"Chemistry","cited_by":3,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Xenon Pharmaceuticals (Canada)","funders":"","keywords":"Drug; Drug discovery; Covalent bond; Pharmacology; Business; Chemistry; Combinatorial chemistry; Medicine; Biochemistry; Organic chemistry","authors":[{"name":"Jan Felix Scholtes","is_ca":true},{"name":"Cristóbal Alhambra","is_ca":false},{"name":"Philip A. Carpino","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1111098228938742,"gpt":0.3708849694896212,"spread":0.259775146595747,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0005184041,0.001279966,0.002461266,0.0008816819,0.0001692245,0.0002692978,0.0008742307,0.0006242879,0.0003650046],"category_scores_gemma":[0.00003527033,0.001042661,0.001436282,0.00340703,0.00006378788,0.0001368575,0.0001959506,0.00153199,0.0001652819],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001144323,"about_ca_system_score_gemma":0.0001524733,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002073342,"about_ca_topic_score_gemma":0.00006034812,"domain_scores_codex":[0.9942538,0.0002510922,0.001745609,0.001991442,0.0008641753,0.0008938598],"domain_scores_gemma":[0.9970886,0.0004687917,0.0007414304,0.001436574,0.00005245378,0.0002121104],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0003186504,0.002851364,0.0002815477,0.005334145,0.003762654,0.00007043756,0.002043187,0.0001141994,0.0003045548,0.0001502226,0.001732491,0.9830365],"study_design_scores_gemma":[0.002775339,0.000106653,0.0001023236,0.02085124,0.001301565,0.00001972503,0.0007025947,0.001612409,0.0008780617,0.000109321,0.9693481,0.002192663],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.002993002,0.9921561,0.00001574501,0.0003879148,0.000528197,0.0006793314,0.0004021864,0.0002195869,0.002617899],"genre_scores_gemma":[0.06164114,0.9286836,0.00001413265,0.000149378,0.0004787231,0.001810135,0.004531578,0.0001938897,0.002497383],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9808439,"threshold_uncertainty_score":0.9999952,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2027041011","doi":"10.1517/13543776.17.3.277","title":"Therapeutic advances in the treatment of osteoporosis","year":2007,"lang":"en","type":"article","venue":"Expert Opinion on Therapeutic Patents","topic":"Bone health and treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McMaster University","funders":"","keywords":"Osteoporosis; Medicine; Strontium ranelate; Anabolic Agents; Bisphosphonate; Teriparatide; Pharmacology; Intensive care medicine; Internal medicine; Bone mineral","authors":[{"name":"Julian Mathoo","is_ca":true},{"name":"Lisa Becker","is_ca":true},{"name":"Dinesh Kumbhare","is_ca":true},{"name":"Jonathan D. Adachi","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.0757609616107818,"gpt":0.3858486133101487,"spread":0.3100876516993669,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002276201,0.0002215753,0.0003379407,0.0001472195,0.00007260995,0.000005996056,0.0001005177,0.00009270047,0.00005202827],"category_scores_gemma":[0.000004557772,0.0001225149,0.0001295053,0.0002537407,0.00006438855,0.00006020985,0.000004116384,0.00008362699,0.00003951156],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000163639,"about_ca_system_score_gemma":0.00004528937,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001621274,"about_ca_topic_score_gemma":0.00002364495,"domain_scores_codex":[0.9984658,0.00009018596,0.0004078673,0.0002590392,0.000392427,0.0003846527],"domain_scores_gemma":[0.9991625,0.0001717466,0.0001213674,0.0004052533,0.00003720708,0.0001019303],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.001654958,0.00430381,0.06786903,0.00002056111,0.00009823327,0.00002225347,0.006028298,0.000001430422,0.0005270833,0.000311224,0.00001828614,0.9191448],"study_design_scores_gemma":[0.01314395,0.01132788,0.5579554,0.0002404644,0.00003276901,0.00004851845,0.002660793,0.00004070513,0.01404838,0.0006034969,0.3996179,0.0002796745],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.7452036,0.2373086,0.0002402795,0.004376193,0.002085933,0.003455813,0.00001932366,0.000108663,0.007201586],"genre_scores_gemma":[0.9598805,0.03672419,0.00008981872,0.002993602,0.00007190817,0.00009456062,0.00002982719,0.00002156094,0.00009401141],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.9188651,"threshold_uncertainty_score":0.4996012,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4413414271","doi":"10.1080/13543776.2025.2548586","title":"Implementation and outcomes of China’s drug patent linkage system: lessons from international experience","year":2025,"lang":"en","type":"review","venue":"Expert Opinion on Therapeutic Patents","topic":"Intellectual Property and Patents","field":"Business, Management and Accounting","cited_by":2,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Business; Drug; Linkage (software); China; Pharmacology; Medicine; Process management; Public relations; Political science; Biology; Gene; Genetics","authors":[{"name":"Yu Chen","is_ca":false},{"name":"Xinjuan Liu","is_ca":false},{"name":"Suju Li","is_ca":false},{"name":"Zhenyu Xu","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.261692608842277,"gpt":0.3822294978361596,"spread":0.1205368889938826,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002114562,0.0005432699,0.001107674,0.0004518946,0.00018703,0.0001913845,0.0006344148,0.0001901596,0.0003459905],"category_scores_gemma":[0.00003252475,0.0003852836,0.0003281134,0.0002499071,0.00006169462,0.0003671611,0.0003075091,0.0002420164,0.0001202826],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001131605,"about_ca_system_score_gemma":0.00005132769,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002169935,"about_ca_topic_score_gemma":0.00001155942,"domain_scores_codex":[0.9975902,0.00009358976,0.0008967946,0.0006253944,0.0005025886,0.0002913724],"domain_scores_gemma":[0.9986519,0.0001231446,0.0007026952,0.000386785,0.0001132177,0.00002223229],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00004279183,0.0001594807,0.0004829583,0.002918625,0.0004958106,0.000003367823,0.0007737098,0.000001003567,0.00000350346,0.001444981,0.000778722,0.9928951],"study_design_scores_gemma":[0.0008543826,0.0000236058,0.0009926679,0.01269224,0.0001148481,0.0000014933,0.001275516,0.0002243163,0.00001935229,0.00008473681,0.9831675,0.0005493511],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0002848983,0.9892921,0.0001790132,0.0003141861,0.00617605,0.001145188,0.0001354166,0.0001147544,0.002358342],"genre_scores_gemma":[0.02710466,0.9701128,0.00002491096,0.0007089568,0.0005053291,0.000268104,0.0009195977,0.00005158711,0.0003040306],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9923457,"threshold_uncertainty_score":0.9998599,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2102449842","doi":"10.1517/13543776.10.5.675","title":"Tyrosine phosphatases: cellular functions and therapeutic potential","year":2000,"lang":"en","type":"article","venue":"Expert Opinion on Therapeutic Patents","topic":"Protein Tyrosine Phosphatases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Smiths Detection (Canada)","funders":"","keywords":"Protein tyrosine phosphatase; Tyrosine; Tyrosine phosphorylation; Receptor tyrosine kinase; Phosphorylation; Protein phosphorylation; Biochemistry; Tyrosine kinase; SH2 domain; Platelet-derived growth factor receptor; Cell biology; Proto-oncogene tyrosine-protein kinase Src; Phosphatase; Chemistry; Biology; Signal transduction; Protein kinase A; Receptor; Growth factor","authors":[{"name":"Amy G Klann","is_ca":true},{"name":"Raymond A. Miller","is_ca":false},{"name":"Eric D. Norman","is_ca":true},{"name":"Eric Klann","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.0197475529811363,"gpt":0.2656236591770438,"spread":0.2458761061959075,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001097749,0.000326225,0.0001993387,0.00005068975,0.000242816,0.0000607092,0.0002371262,0.0001672945,0.0006426517],"category_scores_gemma":[0.000009031864,0.0002909935,0.0001062637,0.0001116225,0.0001406639,0.00001052493,0.00005904525,0.0001184416,0.0001873696],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001985165,"about_ca_system_score_gemma":0.00003629331,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00004906854,"about_ca_topic_score_gemma":8.805106e-7,"domain_scores_codex":[0.9983837,0.000107309,0.000264083,0.0006008878,0.0002534885,0.0003905169],"domain_scores_gemma":[0.9991513,0.00001157569,0.00007117585,0.0005711845,0.00004497369,0.000149796],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.001540696,0.0007317917,0.0005909149,0.00001699182,0.0003520703,0.00001263297,0.00009490026,0.0001697246,0.4691136,0.000886524,0.00642608,0.5200641],"study_design_scores_gemma":[0.002101057,0.001064691,0.002383331,0.00004575107,0.00001500364,0.00003225152,0.00006386032,0.0002297254,0.5757854,0.0002687812,0.4174803,0.0005299022],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"review","genre_gemma":"empirical","genre_scores_codex":[0.2592227,0.7270936,0.005620013,0.001768568,0.002635903,0.001733085,0.000602725,0.0002416984,0.001081645],"genre_scores_gemma":[0.9818469,0.01273401,0.0001273021,0.002858878,0.0004296913,0.0001189172,0.0008839963,0.00006150887,0.0009388096],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.7226241,"threshold_uncertainty_score":0.9999542,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4412046485","doi":"10.1080/13543776.2025.2529217","title":"Recent advances in tropomyosin receptor kinase (TRK) inhibitors: a 2023–2024 patent landscape review","year":2025,"lang":"en","type":"review","venue":"Expert Opinion on Therapeutic Patents","topic":"Cytokine Signaling Pathways and Interactions","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Alberta; University of British Columbia; McMaster University","funders":"","keywords":"Trk receptor; Kinase; Receptor; Pharmacology; Medicine; Chemistry; Internal medicine; Biochemistry","authors":[{"name":"Minh Thong Le","is_ca":true},{"name":"Elena Timakova","is_ca":true},{"name":"Ralf Schirrmacher","is_ca":true},{"name":"Justin J. Bailey","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.111938606311881,"gpt":0.3980883209426094,"spread":0.2861497146307284,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003868449,0.0008907121,0.002687163,0.0007292039,0.0001075552,0.00004475093,0.0003155068,0.0003926464,0.002865124],"category_scores_gemma":[0.0001840599,0.0006409587,0.0009451951,0.001328086,0.00005055798,0.0001358328,0.0000980728,0.001043619,0.0005448406],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005698082,"about_ca_system_score_gemma":0.0005212297,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002330042,"about_ca_topic_score_gemma":0.000003600588,"domain_scores_codex":[0.9956306,0.000493128,0.001627191,0.001033593,0.000636395,0.0005791598],"domain_scores_gemma":[0.9979435,0.0002376382,0.0005478463,0.0008596729,0.0001756267,0.0002357287],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001215052,0.0008029444,0.000009012993,0.01621986,0.000183263,0.00002319488,0.00005211344,4.351943e-7,0.00001565531,0.00002459175,0.03098773,0.9515597],"study_design_scores_gemma":[0.0008079099,0.000448893,0.000002068136,0.2776378,0.0001113784,0.00002625388,0.00003475584,0.000006107246,0.00003006929,0.00000767533,0.7204897,0.0003973609],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[6.924658e-7,0.9862953,0.00001155554,0.001287144,0.007100411,0.002776887,0.00014434,0.000100914,0.002282784],"genre_scores_gemma":[0.000002051349,0.9920204,0.00005119477,0.002728164,0.0008126894,0.001287971,0.001250004,0.00009864286,0.0017489],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9511623,"threshold_uncertainty_score":0.9996042,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2179086760","doi":"10.1517/13543776.2016.1118062","title":"Evaluation of WO2015042088 A1 - a novel urea-based scaffold for TrkA inhibition","year":2015,"lang":"en","type":"article","venue":"Expert Opinion on Therapeutic Patents","topic":"Nerve injury and regeneration","field":"Neuroscience","cited_by":1,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Alberta","funders":"","keywords":"Trk receptor; Tropomyosin receptor kinase A; Chemistry; Kinase; Pharmacology; Biochemistry; Receptor; Nerve growth factor; Biology","authors":[{"name":"Vadim Bernard‐Gauthier","is_ca":true},{"name":"Ralf Schirrmacher","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.4187022352765148,"gpt":0.4125667785736195,"spread":0.006135456702895337,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001217111,0.0001776344,0.00017629,0.0001470313,0.0001131446,0.00002993529,0.0001337552,0.0001178096,0.00002629175],"category_scores_gemma":[0.000242109,0.0001455098,0.0001049139,0.0002030518,0.0000674627,0.0001887043,0.00001398632,0.00006095356,0.0000236296],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001437868,"about_ca_system_score_gemma":0.0001869507,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001176673,"about_ca_topic_score_gemma":0.00000109623,"domain_scores_codex":[0.997638,0.0003444956,0.0003350752,0.0003900023,0.001079495,0.0002128605],"domain_scores_gemma":[0.9989207,0.0001035286,0.0002183911,0.0002856253,0.0003745112,0.00009728754],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0004427122,0.0007171617,0.00002420886,0.0000086592,0.00001225172,1.831893e-7,0.0003368871,0.001737269,0.9594283,0.002100024,0.0006572709,0.03453509],"study_design_scores_gemma":[0.004444592,0.0007359977,0.0001339802,0.00007646618,0.00001129255,0.000002305013,0.00004577509,0.0597598,0.9291775,0.001614748,0.0038226,0.0001749957],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.90599,0.002427473,0.07164816,0.003774046,0.00903641,0.004867904,0.0002322402,0.0002934068,0.001730343],"genre_scores_gemma":[0.9974185,0.00002716812,0.0003202633,0.001558515,0.0002421173,0.000286279,0.0000680136,0.00002673659,0.00005238402],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0914285,"threshold_uncertainty_score":0.5933717,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2124374772","doi":"10.1517/13543770802557740","title":"Non-antibiotic strategies for the prevention/treatment of<i>Clostridium difficile</i>infection","year":2008,"lang":"en","type":"article","venue":"Expert Opinion on Therapeutic Patents","topic":"Clostridium difficile and Clostridium perfringens research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"National Research Council Canada; Institute for Biological Sciences","funders":"","keywords":"Clostridium difficile; Metronidazole; Medicine; Antibiotics; Vancomycin; Intensive care medicine; Enterocolitis; Diarrhea; Disease; Internal medicine; Microbiology; Bacteria; Biology; Staphylococcus aureus","authors":[{"name":"Rhonda KuoLee","is_ca":true},{"name":"Wangxue Chen","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1295508869388775,"gpt":0.37628800678545,"spread":0.2467371198465726,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001315023,0.0003244293,0.0004560894,0.0001563691,0.0003783441,0.00002174109,0.0001451786,0.0001492881,0.00009902033],"category_scores_gemma":[0.00002241419,0.0002047597,0.0004501305,0.0002952087,0.0001906842,0.00007522066,0.00002539639,0.0001374603,0.00005715584],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002312524,"about_ca_system_score_gemma":0.000356969,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002353698,"about_ca_topic_score_gemma":0.000003077836,"domain_scores_codex":[0.9980417,0.0000584271,0.0004737961,0.000418456,0.0005606757,0.0004469362],"domain_scores_gemma":[0.9986696,0.0002195038,0.0001649624,0.0005998908,0.0002173422,0.000128744],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.01184918,0.02156062,0.01902162,0.0004582046,0.004188228,0.00006493263,0.006184689,0.0007016701,0.6920255,0.001772827,0.00938486,0.2327877],"study_design_scores_gemma":[0.008283737,0.01086213,0.01739096,0.0002718356,0.00009047781,0.000127981,0.0007913381,0.002280868,0.9061486,0.0001142805,0.05323632,0.0004015221],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.981836,0.008288679,0.002136474,0.001627179,0.001595953,0.003213529,0.0000423819,0.0001128772,0.001146985],"genre_scores_gemma":[0.9744924,0.02374588,0.00006720344,0.000161907,0.0005491729,0.0002055677,0.00008453245,0.00004947977,0.0006438356],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2323862,"threshold_uncertainty_score":0.8349858,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2013882224","doi":"10.1517/13543770802554275","title":"Recently patented agents with possible antipsychotic indication","year":2008,"lang":"en","type":"article","venue":"Expert Opinion on Therapeutic Patents","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"University Health Network","funders":"","keywords":"Antipsychotic; Agonism; Medicine; Mechanism (biology); Pharmacology; Atypical antipsychotic; Pharmacodynamics; Antagonism; Mechanism of action; Psychiatry; Receptor; Schizophrenia (object-oriented programming); Biology; Internal medicine; Political science; Pharmacokinetics","authors":[{"name":"Roger S. McIntyre","is_ca":true},{"name":"Candy W. Y. Law","is_ca":true},{"name":"Mohammad Alsuwaidan","is_ca":true},{"name":"Hanna O. Woldeyohannes","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1228857204877622,"gpt":0.3569428553952568,"spread":0.2340571349074946,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008053392,0.0002465842,0.0002637486,0.0002228483,0.0002210108,0.00001813066,0.0001289726,0.00009051575,0.0003518982],"category_scores_gemma":[0.00001266465,0.0001637032,0.00008588939,0.0003545061,0.00009831167,0.00008948983,0.00001738633,0.0001908517,0.0004883588],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000150123,"about_ca_system_score_gemma":0.0001523566,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00003269333,"about_ca_topic_score_gemma":0.00000139661,"domain_scores_codex":[0.9980613,0.00009387456,0.0002386271,0.0004304314,0.0007566246,0.0004191535],"domain_scores_gemma":[0.9989766,0.00002874651,0.00009641204,0.0004812558,0.0001083376,0.0003086555],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0746017,0.01087621,0.6016561,0.00006875501,0.002316201,0.0008522138,0.00303718,0.00001122254,0.006952296,0.0005091871,0.00874103,0.2903779],"study_design_scores_gemma":[0.01459442,0.003324629,0.9656643,0.0003114641,0.00001393868,0.0003216254,0.0001031962,0.0003276529,0.009012544,0.0001291015,0.005927263,0.0002698718],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9908455,0.003126624,0.0002185622,0.002735326,0.0005087559,0.001145285,0.00001028887,0.000181203,0.001228445],"genre_scores_gemma":[0.9890221,0.008062585,0.0005505246,0.001430392,0.0001142388,0.0001238257,0.0002138019,0.00004503083,0.0004375025],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3640081,"threshold_uncertainty_score":0.6675624,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2117496910","doi":"10.1517/13543776.18.9.975","title":"Structural biology in the battle against BCR-Abl","year":2008,"lang":"en","type":"article","venue":"Expert Opinion on Therapeutic Patents","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McGill University","funders":"Vertex Pharmaceuticals; Bristol-Myers Squibb; Boehringer Ingelheim","keywords":"Imatinib; Chronic myelogenous leukemia; Tyrosine kinase; Drug resistance; ABL; Tyrosine-kinase inhibitor; Drug; Cancer research; Pharmacology; Medicine; Leukemia; Biology; Cancer; Immunology; Myeloid leukemia; Internal medicine; Receptor; Genetics","authors":[{"name":"Bhushan Nagar","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1027041500105693,"gpt":0.3470829673624465,"spread":0.2443788173518772,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001121483,0.000241815,0.0002929839,0.0001143618,0.0001355406,0.000007944217,0.0002233254,0.000136112,0.0001889689],"category_scores_gemma":[0.00004105279,0.0001442257,0.0001052594,0.0001956045,0.0001305909,0.00004879684,0.00002917618,0.0002566853,0.0002043094],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000393836,"about_ca_system_score_gemma":0.0001241081,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001266976,"about_ca_topic_score_gemma":0.000002348475,"domain_scores_codex":[0.9985106,0.0001769299,0.0002842306,0.0003529186,0.0002844507,0.0003908779],"domain_scores_gemma":[0.9991137,0.0001877585,0.00007272774,0.0005187786,0.00002846673,0.00007852016],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.002723685,0.002678586,0.475282,0.00006183094,0.001046208,0.0006958309,0.02863349,0.00009789615,0.03093969,0.002113552,0.01017359,0.4455536],"study_design_scores_gemma":[0.02385741,0.002342262,0.7893287,0.0003117691,0.0000169948,0.000742137,0.00109145,0.002141274,0.006179887,0.0004725688,0.1727409,0.000774636],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9877893,0.005492812,0.00001756579,0.002008975,0.001724351,0.0005714195,0.000009784949,0.00007104212,0.00231478],"genre_scores_gemma":[0.9910434,0.003170425,0.00008320613,0.005045254,0.000281603,0.00008023951,0.0001424494,0.0000280951,0.0001253512],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.444779,"threshold_uncertainty_score":0.5881353,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4417222214","doi":"10.1080/13543776.2025.2602703","title":"Tricyclic boronic acids as broad-spectrum serine and metallo-β-lactamase inhibitors with <i>in vitro</i> activity against <i>Acinetobacter baumannii</i> : a patent evaluation (US 2025/0223303)","year":2025,"lang":"en","type":"review","venue":"Expert Opinion on Therapeutic Patents","topic":"Synthesis of β-Lactam Compounds","field":"Chemistry","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"Queen's University","keywords":"Scope (computer science); Context (archaeology); Serine; Tricyclic; Enzyme; Boronic acid","authors":[{"name":"Alen Krajnc","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.07328824272488464,"gpt":0.3353653821753039,"spread":0.2620771394504193,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.000823845,0.001864765,0.003053514,0.0007915631,0.000279701,0.0002504822,0.0008496865,0.0009077556,0.0002910561],"category_scores_gemma":[0.0001024463,0.001497823,0.0007339066,0.0008607183,0.0001633189,0.0004157476,0.0003221714,0.001297456,0.00008213471],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00176356,"about_ca_system_score_gemma":0.0008681415,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002033851,"about_ca_topic_score_gemma":0.00001543328,"domain_scores_codex":[0.9928868,0.0008556919,0.001382425,0.002096972,0.001601926,0.001176206],"domain_scores_gemma":[0.9961663,0.0006165254,0.00103053,0.001702629,0.000128757,0.0003551964],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.001051723,0.001108379,0.0001300919,0.003038492,0.001082644,0.00003977486,0.0001495135,0.000005373074,0.003231682,0.000004755294,0.0001432486,0.9900143],"study_design_scores_gemma":[0.00660018,0.0004256525,0.0002543729,0.02234951,0.0006333365,0.00008435088,0.00009066035,0.000366933,0.01598157,0.00004611765,0.9506602,0.002507095],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.01576697,0.9774538,0.000008474243,0.0003360212,0.0009861189,0.001904771,0.000116781,0.0002491436,0.003177959],"genre_scores_gemma":[0.06211622,0.9336904,0.00003437681,0.0005638029,0.0004124423,0.001568366,0.0007784167,0.0002493028,0.0005867085],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9875072,"threshold_uncertainty_score":0.9994097,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4256674571","doi":"10.1517/eotp.13.7.979.22985","title":"Epilepsy drug review: patent activity from 1999 to 2002","year":2003,"lang":"en","type":"article","venue":"Expert Opinion on Therapeutic Patents","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Women's Health Research Institute","funders":"","keywords":"Drug; Epilepsy; Pharmacology; Drug development; Medicine; Business; Psychiatry","authors":[{"name":"Mark R. Bowlby","is_ca":true},{"name":"Wayne E. Childers","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1706224520878894,"gpt":0.3322660331660597,"spread":0.1616435810781704,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.000464764,0.0003196055,0.0006048853,0.0001500427,0.0001254775,0.00005819526,0.0003541695,0.00009876434,0.003760712],"category_scores_gemma":[0.00006983469,0.000332518,0.0002200837,0.0002068334,0.00003405911,0.00014839,0.00005319656,0.0002310111,0.008814076],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001959817,"about_ca_system_score_gemma":0.00002275695,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003936263,"about_ca_topic_score_gemma":0.00000326604,"domain_scores_codex":[0.9979774,0.00009431571,0.0006303774,0.000697777,0.00007326147,0.0005268587],"domain_scores_gemma":[0.9986452,0.00008638442,0.0002529571,0.0006330513,0.00002255426,0.0003598856],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00060512,0.004090342,0.02911203,0.0002165053,0.00122878,0.00001686891,0.003172449,0.0001814821,0.002007185,0.2141863,0.5054637,0.2397192],"study_design_scores_gemma":[0.0008186029,0.00008121943,0.005622586,0.0001369274,0.000002249662,0.000001151523,0.00001029907,0.0003391176,0.001496792,0.006565598,0.9844742,0.0004512521],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"review","genre_gemma":"empirical","genre_scores_codex":[0.1344505,0.6245427,0.004326316,0.06019541,0.01998469,0.004579734,0.002359498,0.0004474701,0.1491137],"genre_scores_gemma":[0.7893139,0.1221167,0.0002576524,0.08655911,0.0003685197,0.0002362645,0.00004230193,0.00008661969,0.001018963],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.6548633,"threshold_uncertainty_score":0.9999127,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2162925667","doi":"10.1517/13543776.13.7.979","title":"Epilepsy drug review: patent activity from 1999 to 2002","year":2003,"lang":"en","type":"article","venue":"Expert Opinion on Therapeutic Patents","topic":"Epilepsy research and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Women's Health Research Institute","funders":"","keywords":"Epilepsy; Drug; Anticonvulsant; Anticonvulsant drugs; Medicine; Action (physics); Pharmacology; Psychiatry","authors":[{"name":"Mark R. Bowlby","is_ca":true},{"name":"Wayne E. Childers","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1070106361356666,"gpt":0.3617737780236091,"spread":0.2547631418879425,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0002847147,0.0003408903,0.0005332981,0.0001166535,0.0001275444,0.00002289735,0.0001572004,0.00008358825,0.002180144],"category_scores_gemma":[0.00009491436,0.0002471567,0.0002170506,0.000258194,0.00003968719,0.00007209103,0.00003702849,0.0002625124,0.002565974],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002437872,"about_ca_system_score_gemma":0.00009447665,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003375159,"about_ca_topic_score_gemma":0.000004154509,"domain_scores_codex":[0.9973685,0.0003496764,0.0003152089,0.0006147772,0.0007761105,0.0005757423],"domain_scores_gemma":[0.9983095,0.0001121774,0.00008326729,0.0007937442,0.00009814869,0.0006031862],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.003115845,0.009103315,0.0815145,0.0002893505,0.001702699,0.0002622456,0.001549275,0.000005013478,0.02084463,0.0004110209,0.2229432,0.6582589],"study_design_scores_gemma":[0.005268039,0.001840135,0.09758978,0.002698723,0.00003569009,0.00002157455,0.000096681,0.00004105851,0.03816998,0.0002000746,0.8535081,0.0005301872],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"empirical","genre_scores_codex":[0.372556,0.5399538,0.001191537,0.0445278,0.006039839,0.01095047,0.0002901101,0.0006800025,0.02381038],"genre_scores_gemma":[0.8678554,0.1103427,0.000495845,0.01809376,0.0002432845,0.0005523378,0.0001150819,0.00007484326,0.002226783],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.6577287,"threshold_uncertainty_score":0.9999981,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4235008009","doi":"10.1517/eotp.13.10.1491.22914","title":"Therapeutic patents for the treatment of premenstrual syndrome and premenstrual dysphoric disorder: historical perspectives and future directions","year":2003,"lang":"en","type":"article","venue":"Expert Opinion on Therapeutic Patents","topic":"Menstrual Health and Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"St. Joseph’s Healthcare Hamilton","funders":"","keywords":"Premenstrual dysphoric disorder; Etiology; Serotonergic; Medicine; Psychiatry; Physiology; Psychology; Hormone; Internal medicine; Serotonin; Menstrual cycle; Receptor","authors":[{"name":"Lori E. Ross","is_ca":true},{"name":"Meir Steiner","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.058909408830325,"gpt":0.3306736624273774,"spread":0.2717642535970525,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001417929,0.0003448015,0.0004771044,0.0001280038,0.0003756307,0.00001727574,0.00006902282,0.0001509376,0.00005197249],"category_scores_gemma":[0.00001980183,0.000217263,0.0001324742,0.0001881303,0.0001495979,0.00005907531,0.000009805005,0.0001206234,0.000002012633],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003283808,"about_ca_system_score_gemma":0.00009332014,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001923128,"about_ca_topic_score_gemma":0.000005340077,"domain_scores_codex":[0.9982147,0.0001362331,0.0003925721,0.0004966278,0.0003412687,0.0004185823],"domain_scores_gemma":[0.9990354,0.000145062,0.0001463667,0.0003449463,0.0001038373,0.000224383],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.002390144,0.004117736,0.03719861,0.0001819144,0.001023058,0.000004993437,0.01759978,0.000002240589,0.0005189669,0.002818868,0.000157847,0.9339858],"study_design_scores_gemma":[0.01717653,0.02008984,0.2898741,0.0001528291,0.0002165153,0.0003135153,0.02096434,0.0004226266,0.0004274787,0.0007821945,0.6489163,0.0006637194],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.6988813,0.2912391,0.0003340383,0.003262395,0.002580262,0.003264189,0.00003269437,0.00008642855,0.0003196091],"genre_scores_gemma":[0.8922466,0.1063307,0.0002212799,0.0003289326,0.0001575132,0.0003847583,0.00001339304,0.00004282103,0.0002740293],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.9333221,"threshold_uncertainty_score":0.8859727,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4403781693","doi":"10.1080/13543776.2024.2423023","title":"Ectonucleotidase inhibitors: an updated patent review (2017–2023)","year":2024,"lang":"en","type":"review","venue":"Expert Opinion on Therapeutic Patents","topic":"Adenosine and Purinergic Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Université Laval","funders":"","keywords":"Chemistry; Pharmacology; Medicine","authors":[{"name":"Jamshed Iqbal","is_ca":false},{"name":"Sehrish Bano","is_ca":false},{"name":"Imtiaz Khan","is_ca":false},{"name":"Jean Sévigny","is_ca":true},{"name":"Qing Huang","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1443363722778405,"gpt":0.3912386502507594,"spread":0.2469022779729189,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003102925,0.0008539789,0.00118555,0.0001579766,0.0001129345,0.00007790655,0.0006045523,0.0005410583,0.000287163],"category_scores_gemma":[0.00001577326,0.0006113176,0.0007373942,0.0002955092,0.00005748758,0.000009445196,0.0001979771,0.0004291118,0.0007432139],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00006358915,"about_ca_system_score_gemma":0.0001974197,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001938249,"about_ca_topic_score_gemma":3.117058e-7,"domain_scores_codex":[0.9966958,0.0004289763,0.000851329,0.001151134,0.0003765871,0.0004962098],"domain_scores_gemma":[0.9982659,0.00001229197,0.0003264425,0.001066742,0.00008659901,0.0002419986],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00003608432,0.0003192134,8.122726e-7,0.005428635,0.0007696273,0.00005225025,0.00003311402,9.959169e-7,0.0002037351,0.00003493174,0.2986591,0.6944615],"study_design_scores_gemma":[0.0002352843,0.0004636774,3.644412e-7,0.02458145,0.000182028,0.00008710374,0.000009963735,0.000007455558,0.0001271247,0.00001228577,0.9735904,0.0007028117],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.000007104422,0.9960603,0.0000290178,0.0001262415,0.002324417,0.0009722621,0.0001086614,0.00008186998,0.0002900923],"genre_scores_gemma":[0.0000824055,0.988198,0.00002770306,0.002145791,0.001787989,0.0002545235,0.006583157,0.000182645,0.0007377513],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.6937587,"threshold_uncertainty_score":0.9996338,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null}]}